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Genetic based diseases are commonly thought as an “error”, i.e. as the result of
one or few rare mutations in the DNA. While this explanation can work fine for
Mendelian, high penetrance, diseases, it is less plausible for complex diseases (CD).
Indeed, this important class of diseases is characterized by the fact of being caused
by hundreds of variants, each of them “common” in the population and with a small
effect. As a possible explanation for such an apparent paradox, it has been proposed
that variants associated with CD are the result of direct or indirect evolutionary
pressures in ancient times. According to this hypothesis, those variants (or variants
close to them) were selected in our ancestors for being advantageous and that they
became dangerous only recently because of the totally different environment we live
in. Then, the very recent changes in the environment, together with the late onset
characterizing these diseases, provided no time for natural selection to act against
them.
As a first step toward addressing this hypothesis, I analyzed the genomic distribution
of a specific marker of selective pressure, namely FST . I examined, in particular,
its relationship with genes associated to human CD finding indeed suggestions of
positive selection occurred on them.
To better understand the role of natural selection on genes associated with CD I then
focused on two different cases of study corresponding to two different scenarios. In
the first one, I found hints for schizophrenia to be, at least partially, a maladaptive
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by-product of natural selection which acted on vitamin D related genes when first
humans moved to higher latitudes.
In the second example, I focused on the case in which variants increasing the risk for
autoimmune diseases are most likely to be the actual and direct target of selection.
I found that a plausible hypothesis is that the diseases themselves are the results of





Complex diseases in an evolutionary
perspective
In the past years, the main contributions of genetic to medicine were directed towards
the finding of visible chromosomal defects and mutations in genes that interfere with
the specific function of a single gene and thereby cause “Mendelian” or “monogenic”
diseases. The result of this big effort is such that, to date, more than 4,000 disor-
ders are known and, for the majority of them, the molecular mechanism is known
as well (www.omim.org). Many reasons account for this tendency, not last the
technologies not available up to few years ago and the relative simplicity (compared
to other phenotypes) of the study of these disorders. Mendelian diseases, indeed,
although rare are characterized by simple and clear-cut pattern of transmission and
are usually due to one or few highly penetrant and strongly deleterious alleles that
segregate in families.
However, the vast majority of human diseases shows incomplete pattern of pene-
trance and they are usually caused by many genetic and environmental factors and
by (non-linear) interactions among them. To this class of disorders, known as “com-
plex diseases” (CDs), belong those pathologies with the highest prevalence in the
3
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human being, such as cancer, cardiovascular diseases, asthma, diabetes mellitus, etc
[1].
At least until few years ago, the search for genetic mechanisms underlying CDs was
not successful as it was for Mendelian ones [2]. One of the most important reason is
that, because of their intrinsic multi-factoriality, each allele is expected to influence
the disease risk only in a small amount and this can explain why traditional methods
for mapping (e.g. linkage analysis) work poorly. But, with the introduction of high-
density single nucleotide polymorphisms genotyping platforms, the scenario became
different. Genome-wide association studies (GWAS) allowed to unveil many, well
replicated, risk loci associated to common diseases [3]. Moreover, the decrease of
their cost and the possibility of studying even more individuals, also allowed to
identify very subtle signals in a relatively cheap and quick way [4].
A deeper look at these results, however, unveil a subtle evolutionary paradox. Power
of GWAS strongly depends on the frequency of the variant in the sample and in the
population [5]. Indeed, variants which are rare in the population could not even be
present on the array while those that have low frequency in the sample are usually
unable to reach a genome-wide significance threshold. The high consistency of many
of these results, and consequently the likelihood of them being true, supports the
evidence that susceptibility variants are “common” (frequency > 5%) in the popu-
lation. It is worth stressing that this doesn’t means that all the variants affecting
the risk for common diseases needs to be common. Unfortunately, because of the
limits of current technologies, right now this is the range of frequencies we can more
comfortably focus on [6].
Even under the conservative hypothesis that they represent just a piece, more or
less big, of the genetic puzzle explaining CDs, the contribution of those variants
is non negligible. In one of the first large scale GWAS, for example, Zeggini and
colleagues found about 10 variants associated with type 2 diabetes (T2D) mellitus
which frequencies range from 15% up to 45%[7] in a UK samples, and in general
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few variants associated with T2D show an allelic frequency < 10%. Five variants
strongly associated with age-related macular degeneration risk (∼ 50% of explained
variance) shows frequencies above 20% [8].
Overall, the average minor allele frequency of CD-risk variants is about 30% [9].
If we instead look at genetic variation responsible for Mendelian diseases they are
essentially rare ( 1%). From an evolutionary perspective, indeed, it is reasonable
that variants providing strongly deleterious phenotypes, as many Mendelian disor-
ders are, are likely to be removed by purifying selection. But, the fact that a similar
reasoning doesn’t work for CDs, led to the question which represents the aim of this
thesis: why mutations that increase the risk for a disease should be present at such
an high frequency in the human population?.
Several explanations can be hypothesized. First of all, it cannot be excluded that
common variants are just proxies for a set of surrounding rare mutations. More-
over it should be kept in mind that CDs can be sometimes characterized by milder
phenotypes, with late onset and a modest or null impact on reproductive fitness.
However, in some cases both this assumptions have been showed to be false and some
more advanced and general explanations are needed. One of the most intriguing is
the idea that natural selection played, in the past, an important role. Indeed, many
mechanisms underlying CDs become clearer and more understandable if looked from
an evolutionary perspective. Aim of this work will be to clarify how selective pres-
sure could have played a role in the evolution of CDs, to assess on a genome-wide
scale its role, and to exhibit some concrete examples relative to different models.
As an example of how studying and understanding evolution has an even more
important impact in medicine and, eventually, on health, it is worth to remark that
the National Academy of Sciences of USA held on April 2009 in Washington DC
one of its famous Arthur M. Sackler colloquia on the topic “Evolution in Health and
Medicine” [10].
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1.1 Evolutionary models for CDs
The most basic mechanism one can imagine acting on diseases is purifying or neg-
ative pressure. As discussed for Mendelian diseases, indeed, one should expect that
disease alleles are removed from the population due to their deleterious effect. At
the same time, the mutational process re-introduce new disease alleles. At a certain
point, these two forces will reach a balance (mutation–selection balance) between
the input of new mutations and purifying selection that removes them [11] and sus-
ceptibility allele (if rare) will reach an equilibrium frequency approximately equal to
the mutation rate divided by the selection against the allele in heterozygotes. Under
this model, traits are expected to feature an high levels of allelic heterogeneity and
a low prevalence, as it is the case for Mendelian diseases [12].
There are some cases in which also Mendelian disorders are caused by mutations
with a frequency (> 1%). This is the famous case, for example, of β-globin defects
that lead to sickle cell anaemia in homozygotes individuals but protect heterozygotes
against malaria. In this case is reasonable to hypothesize that the allele is kept in
the population because of a balancing selection acting on the heterozygotes.
In 2001, Pritchard investigated the effect of the mutation–selection balance in the
framework of CDs [13]. In this work, he simulated under this model two sets of
neutral and slightly deleterious susceptibility alleles (e.g. with a late and an early
onset effect) contributing susceptibility to a disease and looked at their overall fre-
quency. Interestingly, while in the neutral case susceptibility alleles tend to be either
rare or close to fixation, in the selected case the probability of having alleles at an
intermediate frequencies was considerably higher. This result seems to suggest that
CDs are unlikely to be due to selectively neutral alleles.
More interesting for their usefulness in shedding light on the biological mechanisms
leading to a disease, and central focus of this thesis, are the cases in which suscep-
tibility alleles for CDs underwent a positive selection. This apparently paradoxical
6
1.1 Evolutionary models for CDs
cases, that as we will see in Chapter 2 are not unusual, can be explained by different
general models.
The first and more simple scenario is the case in which one gene, one allele or
linked alleles, have an antagonistic pleiotropic effect and one of the phenotypes has
a beneficial effect in terms of fitness which overcomes (or reaches a trade-off) the
detrimental effects of another trait. For example, the gene p53 helps, in human,
to prevent cancer by preventing cells with DNA damages from dividing, but it can
also suppress the division of stem cells, which allows the body to renew and replace
deteriorating tissues during aging [14]. In Chapter 3 I will present one of this cases
of “indirect” positive selection in which genes increasing the risk for schizophrenia
also have a beneficial effect of vitamin D metabolism. Indeed, while vitamin D defi-
ciency can severely compromise the capability of individuals to reproduce (causing
for example rickets and pelvic deformities), schizophrenia has a late onset and a
scarce influence on reproductive fitness.
A similar case is the one in which different adaptations conflict, which requires a
compromise between them to ensure an optimal cost-benefit trade-off. This is, for
example, the very well known case of skin pigmentation, which needs to guarantee
protection from UV (favored in dark skins) and at the same time allow the skin
synthesis of vitamin D (favored in light skin).
All the models discussed so far assume that the selective force is constant and
doesn’t change in the time. However, this assumption is in many case far from
being true both because environment changes over time and because our ancestors
moved in several moments of our history to different places finding different living
conditions.
A first scenario, of “spatially varying selection”, is the one in which peoples adapted
to environmental conditions specific for one place and, after moving to different
places and different living conditions, the variants that so far provided an advan-
tage became deleterious. One of the best known example is the “sodium retention”
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hypothesis, proposed to try to explain the inter-ethnic differences in the the preva-
lence of hypertension. The idea is that the ancestral populations living in equatorial
Africa adapted to the hot and humid climate thanks to an increase of the rate of
sodium retention. When then peoples moved to cooler and drier climate, those vari-
ants lost their advantageous and became even detrimental making individuals more
prone to hypertension.
Conceptually similar is the case of “timing varying selection”, according to which
populations adapted to specific environment and life styles and, when these changed,
variants conferring adaptation became dangerous. Stated in a different way, this hy-
pothesis asserts that CDs, or at least a subset of them, could be the result of an
environmental mismatch between our ancestors’ and ours life styles. The impact of
the selective shifts resulting from these transitions has been formalized, for type 2
diabetes and obesity, by Neal in 1962 and is known as “thrifty genotype”. During
the hunter-gatherer period, populations underwent continuous cycles of feast and
famine. In such environment, it is easy to figure out that genetic variants allowing
a better and more efficient fats and carbohydrates storage were extremely advan-
tageous, increasing the chances for individuals to survive and reproduce. As the
transition from that life style occurred to more reliable food sources and different
dietary patterns, that “thriftiness” became detrimental.
In both the previous scenarios of varying selection, there is a relatively recent change
in the selective pressures acting on biological processes responsible for maintaining
the correct balance between the organism and its environment. The recent environ-
mental change disrupts this balance leading, in turn, to new detrimental phenotypes
since it was too rapid to allow the gene pool to re-adapt accordingly. According to
this model it is thus plausible that the ancestral version of susceptibility alleles to
CDs should reflect adaptations in early populations, when these alleles were main-
tained by purifying selection [15].
I will discuss in Chapter 4 the case of autoimmune diseases. It has been hypothe-
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sized, indeed, that variants increasing the risk for autoimmune diseases were actually
advantageous in environments with high pathogens load and variability. Today, the
higher sanitary conditions typical of industrial societies “transformed” that ances-
tral advantage in an increased risk for autoimmune diseases. It will be also clear that
being able to estimate the timing when selection occurred/started helps in testing
this hypothesis and in understanding how those big changes in our ancestors living
styles had an impact today on CDs risk.
In the entire work I will assume that selection acted on a single gene at a time.
However, this is a reductive hypothesis which will discard all the cases in which
the change in the fitness is due to many genes, each of them with a moderate to
small effect. The search for signatures of “polygenic adaptation” is still at the very
beginning and in Chapter 5 I will present one of the first case of study.
Results presented in chapters 2, 3 and 5 are published on scientific journals and
the respective references are reported at the beginning of each chapter. Results
discussed in chapter 4, instead, are in part preliminary and the manuscript is in
preparation. For this last project I want to acknowledge the principal investigator
Anna Di Rienzo from the University of Chicago and all the peoples in her group.
I want to specifically acknowledge Gorka Alkorta-Aranburu, which was responsible
for all the biological and experimental aspects of the project, and David Witonsky,
which worked on all the preliminary aspects, for their constant support and the
interesting discussions. I also want to thank Dick Hudson and Molly Przeworski




A genome-wide assessment of
selective pressure on human genome
and its relationship with diseases
Genetic differences are present in humans at both individual and population level.
Human genetic variations are studied for their evolutionary relevance and for their
potential medical applications. This studies can help scientists in understanding
ancient human population migrations as well as how selective forces act on the
human being [16, 17].
According to the theory of neutral variation, most of the genetic variability within
species are caused by random drift of selectively neutral polymorphic alleles [18].
Genetic drift should affect all loci across the genome in a similar manner. There-
fore, when a locus shows extraordinary high or low levels of variability this may be
interpreted as evidence for natural selection [19]. High levels of population differen-
tiation can suggest the acting of a positive selection of advantageous alleles in one
or more populations. On the contrary, lower levels of population differentiation can
be considered as the effect of balancing selection that tends to maintain a constant
proportion of alleles across all populations [20].
11
Chapter 2 Genome-wide scan
Population differentiation is sensitive to a variety of demographic factors (including
the rate of drift within populations and the extent of gene flow among them), making
it difficult to rule out demographic scenarios that could account for the observed
variations. Another class of tests is aimed to detect signature of natural selection by
comparing data from different species. These tests explore the fact that mutations
can be synonymous and non synonymous, and that non-synonymous mutations are
more likely to have an effect on individual fitness. This method is also known as
dN/dS. Results obtained by this comparative approach are rarely interpreted in
terms of population genetics theory [21].
The human population is also not homogeneous in terms of disease susceptibil-
ity. Risks of common diseases are substantially different among ethnic groups [22].
The understanding of population genetic differentiation, especially in genes associ-
ated with diseases, can help to explain the observed variations in the prevalence
of diseases. It is not difficult to forecast that, in the future, genetic structure of
populations can be used in public health management [23]. Moreover, natural se-
lection on genes that underlie human disease susceptibility has been invoked. In
this framework, ancestral alleles reflect ancient adaptation. With the shift in the
environment, these alleles increase the risk for common diseases [15].
Different strategies to quantify the population genetic differentiation have been elab-
orated [24–30]. One of the most used is a measure devised by Wright and known
as fixation index, or FST [31, 32], which is the amount of genetic variation among
groups relative to a panmictic state. As a test of selection, observed FST values are
compared to those expected under neutrality. The main difficulty of this approach
is to determine the distribution of FST values under neutrality [24]. Recently, how-
ever, the abundance of genetic data available allows the creation of an empirical
genome-wide distribution to be used for the comparisons. Rather than statistically
testing specific loci, we can use their position relative to this distribution to gain
insights about their selective histories. In addition, the abundance of information
about variability of many genes makes it possible to analyze not only single genes,
12
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but also sets of functionally related genes. International HapMap Project [33] by
supplying data of a large number of Single Nucleotide Polymorphisms (SNPs) across
many human populations, is providing an exceptional tool for studying the genetic
structure of human populations.
In the present work we report the results of a genome-wide estimation of FST on
3, 917, 301 SNPs from the latest release of HapMap data. Our results show a het-
erogeneous distribution of FST values among genomic regions. Furthermore, we
studied the relationship between FST and an evolutionary measure obtained by a
comparative interspecific approach. We applied a gene set approach, widely used
for microarray data, to detect biochemical pathways under selection. Finally, we
detected a signature of selection within genes associated with complex diseases. 1
2.1 Results
Using FST , we estimated populations differentiation for 3, 917, 301 SNPs in popula-
tion samples from the International HapMap Project data (Public release 27, merged
II + III). To retain the largest number of SNPs broadly reflecting a continental sub-
division, we used data from Yoruba (Africa), Japanese (Asia), Han Chinese (Asia)
and CEPH (European descendant) individuals. Combining data from these popula-
tions we were able to compare the largest set of genotyped SNPs up to now available.
We pooled Japanese and Han Chinese samples due to their geographical closeness.
Furthermore, this pooling allowed us to compare our data with previous studies [25,
34]. FST was estimated according to Weir and Cockerham [32, 35].
After exclusion for Minor Allele Frequency (MAF), we obtained a final SNP sample
1The results presented in this chapter are published in: Amato R, Pinelli M, Monticelli A, Marino
D, Miele G and Cocozza, S. (2009) Genome-wide scan for signatures of human population
differentiation and their relationship with natural selection, functional pathways and diseases.
PLoS ONE 4(11): e7927.
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of 2, 125, 440 SNPs. The mean FST was 0.122 (SE = 5 × 10−5, median = 0.091,
interquartile range = 0.131; see Table 2.1 for more detailed statistics). Figure 2.1
shows distribution of FST values for each chromosome. The median FST values of
SNPs on the autosomal and sexual chromosomes were statistically different (Kruskal-
Wallis test, p-value < 10−16). The median FST values for X and Y chromosomes
were 0.129 (mean = 0.174) and 0.676 (mean = 0.606) respectively and were notably
higher than those of autosomal chromosomes. Also medians between autosomal
chromosomes showed significant differences, but in a very small range of values
(median range = 0.084 to 0.098).
Figure 2.1: Distribution of FST values across chromosomes. For each chro-
mosome, the box length is the interquartile range while the horizontal
line inside it is the value of the median. The whiskers extend to the
most extreme data point < 1.5 times the interquartile range from the




Chr Number of SNPs Mean SD Median IQR
1 160631 0.121 0.110 0.090 0.129
2 182756 0.127 0.114 0.096 0.135
3 141273 0.123 0.111 0.092 0.134
4 131470 0.122 0.112 0.090 0.131
5 138353 0.118 0.107 0.088 0.126
6 142779 0.114 0.104 0.084 0.123
7 114767 0.120 0.110 0.089 0.130
8 119383 0.123 0.110 0.092 0.132
9 97952 0.120 0.108 0.089 0.128
10 110485 0.120 0.110 0.089 0.129
11 106880 0.115 0.105 0.086 0.124
12 96493 0.119 0.108 0.089 0.126
13 83084 0.117 0.104 0.089 0.125
14 67477 0.120 0.107 0.090 0.131
15 59040 0.130 0.116 0.098 0.138
16 59604 0.121 0.108 0.091 0.129
17 50163 0.127 0.114 0.094 0.137
18 62453 0.116 0.103 0.089 0.123
19 32325 0.119 0.109 0.090 0.129
20 51481 0.123 0.113 0.090 0.133
21 28532 0.120 0.110 0.089 0.128
22 26757 0.122 0.109 0.091 0.130
X 61204 0.174 0.153 0.129 0.189
Y 98 0.606 0.282 0.676 0.528
Overall 2125440 0.122 0.111 0.091 0.131
Table 2.1: Per-chromosome statistics of FST values
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For each chromosome, we computed the correlations of all pairs of FST values for
neighbouring SNPs separated by a fixed number of SNPs (1 to 30). This method is
commonly used to assess whether FST values are non randomly distributed across
chromosomes [19, 36]. As expected, we found that correlation plots are different
from those expected from a noisy signal (Figure 2.2). Moreover, scrambling FST
values across each chromosome produced vanishing correlation values demonstrating
that the distribution of data is non-random (data not shown). This result was also
supported by a test for non-randomness of data (Ljung-Box test, p-value < 10−16).
Figure 2.2 shows a clear difference between correlation plots of autosomal and X-
linked SNPs, the latter showing higher autocorrelation values. Chromosome Y was
excluded from this analysis because of the small number of SNPs sampled.
To attribute FST value to genes we followed the approach by Akey et al. and Pikrell
et al. [19, 30, 36], considering FST of a gene the maximum FST value in the gene
region (see 2.3). It is worth stressing that this approach is very conservative for
genes with low FST values.
Selection affects both interspecific (between-species) and intraspecific (within-species)
variability. FST is a measure of intraspecific variability. Estimation of genic dN/dS
is an interspecific measure of variability [21]. We compared the gene FST values that
we obtained with previously reported data from a genome-wide estimation of genic
dN/dS [37]. In that article the authors divided genes into subgroups with strong,
weak and no evidence of positive selection. We compared FST values of genes be-
longing to these subgroups. Genes with both weak and strong evidence of positive
selection showed lower FST values than genes with no evidence of positive selection
(ANOVA, p-value < 0.001; Bonferroni post-hoc, no evidence vs. weak evidence p-
value < 0.02, no evidence vs. strong evidence p-value < 0.005, weak evidence vs.
strong evidence = N.S.; Figure 2.3).
To identify functions potentially under selective pressure, we used an innovative
approach, focusing on gene pathways instead of outliers. We performed this “gene
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Figure 2.2: Correlation between FST values. The correlation is calculated, for
each chromosome, for all pairs of SNPs separated by a fixed number of
intervening SNPs. Black line shows mean value and 2σ error bars of
the correlation of SNPs belonging to autosomal chromosomes. Red line
shows correlation among X-linked SNPs.
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Figure 2.3: Mean FST value of genes with and without interspecific evi-
dence of positive selection. Genes were grouped according to the
strength of evidence of their positive selection across six species [37].
Vertical bars represent 95% confidence interval.
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Pathway Name KEGG ID Size FDR
Enriched by
high FST genes
Axon guidance HS04360 126 < 0.001
Focal adhesion HS04510 194 0.008
ECM receptor interaction HS04512 85 0.009
Regulation of actin cytoskeleton HS04810 199 0.010
Adherens junction HS04520 75 0.010
Calcium signaling pathway HS04020 168 0.010
Enriched by
low FST genes
Antigen proc. and presentation HS04612 70 0.001
Table 2.2: Leading edge genes of the high FST enriched KEGG pathways
identified by GSEA. For each pathway is showed the name, the KEGG
ID, the number of genes included in the pathway and the p-value after
the False Discovery Rate (FDR) correction.
set” analysis using the Gene Set Enrichment Analysis (GSEA) algorithm [38, 39].
GSEA is oriented to identify sets of functionally related genes and is currently used
in the analysis of microarray data. Screening the KEGG pathway database by
GSEA, we identified 6 KEGG pathways enriched by genes with high values of FST
and one pathway enriched by genes with low values of FST (Table 2.2). In this
method, the enrichment of a pathway is mainly driven by a group of genes that are
called “leading edge genes” (see 2.3). Figure 2.4 shows the leading edge genes for
the six pathways with high FST values. A partial overlap of genes among pathways
is present.
We then studied populations differentiation of genes associated with complex dis-
eases. We used the Genetic Association Database (GAD) to select genes annotated
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Figure 2.4: Leading edge genes of the high FST enriched KEGG pathways
identified by GSEA. Genes are indicated by gene symbols. Red box
marks the presence of that gene, as leading edge gene, in that pathway.
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Figure 2.5: Mean FST value of genes associated to complex diseases. Genes
found positively associated with complex diseases according to the Ge-
netic Association Database are compared with the remaining ones. Ver-
tical bars represent 95% confidence interval.
as having positive association with complex diseases. We compared FST values
of these genes with those where no association had been positively found. Genes
associated with complex diseases showed a significant higher mean value of FST (t-
test, p-value < 0.001; Moving Block Bootstrap, empirical p-value = 0.0005; Figure
2.5). Then, we divided diseases in subgroups according to the GAD classification
of diseases. Figure 2.6 shows that large differences of FST values exist among dis-
ease classes, while mean FST values are usually higher than those of non associated
genes.
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Figure 2.6: Mean FST values of genes in different disease classes. Genes were
grouped according to the diseases classification of Genetic Association
Database. Vertical bars represent 95% confidence interval. Horizontal
solid and dashed lines represent mean value and 95% confidence interval




The study of the evolutionary forces acting in diseases and physiological traits is
an exciting field that may drive further researches and, in the future, public health
policies. The study of population genetic differentiation could help the understand-
ing of human evolution, demographic history and disease susceptibility [40]. To
study population differentiation we performed a genome-wide FST calculation us-
ing the latest available data release from the HapMap. Using this release we were
able to increase both the number of SNPs and the number of individuals analyzed
in comparison to recent analogous studies [29]. We focused on samples from three
different continents (Africa, Asia, Europe) to obtain a broad but sound measure of
populations differentiation.
We found an overall mean FST value (0.122) broadly consistent with previous esti-
mations [19, 29, 36]. The slightly higher value that we obtained could be explained
by the exclusion of SNPs with MAF < 0.05 and the inclusion of heterochromosomes
in the calculation. Indeed, as expected [19], we observed a significantly higher me-
dian FST value of X-linked SNPs with respect to the autosomal ones. Furthermore,
we found median FST value of Y-linked SNPs to be significantly higher than both
the autosomal and the X-linked ones. Previous data from smaller datasets suggested
a similar phenomenon [41], but, in our knowledge, this is the first observation made
on Y chromosome FST in a more robust framework. The higher population dif-
ferentiation for X and Y chromosomes can be due to various causes: their smaller
effective population size (three-quarter and one-quarter of autosomes, respectively),
the lower mutation and recombination rates and the different selective pressure be-
tween genders have been invoked [19, 21, 42].
Keinan et al. showed that there was a period of accelerated genetic drift on chro-
mosome X associated with the human dispersal out of Africa. In particular, they
estimated the autosome-to-X genetic drift ratio between North Europeans and East
Asians is consistent with the expected 3/4 while it is significantly reduced between
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North Europeans and West Africans, and between East Asians and West Africans
[43]. As possible explanations they suggested that a gender-biased process reduced
the female effective population size, or that an episode of natural selection affecting
chromosome X was associated with the founding of non-African populations. Our
results are consistent with these finding. We computed population pair-wise FST
and we found that the autosome-to-X genetic drift ratios (Q), estimated as in [43],
are compatible with those reported in [43] (Asia-Europe Q = 0.72; Asia-Africa Q =
0.66; Europe-Africa Q = 0.65).
The weak but significant correlation that we found among FST values of neighbouring
markers demonstrated that they are non-randomly distributed along chromosomes.
This result confirms previous observations made on smaller datasets [19, 36]. We
extended for the first time this observation to the X chromosome and we found
that correlation was slightly stronger than that of autosomes. It has been observed
that correlation between SNPs is proportional to Linkage Disequilibrium (LD) [36].
Therefore, the higher value of autocorrelation that we found can be explained by
the higher value of LD in X chromosome [36].
Population genetics approach has been largely used for studying natural selection.
Other approaches include the comparative one, in which data from different species
are used. The most commonly used method is to compare the ratio of nonsynony-
mous mutations per nonsynonymous site to the number of synonymous mutations
per nonsynonymous site (dN/dS). Data from comparative studies and from popula-
tion genetics are poorly connected. We found that genes with a high dN/dS ratio,
indicating positive selection, showed a significantly lower FST mean value. In our
knowledge this represents the first attempt to connect human population genetic
data and comparative data at a genome-wide level. Our finding does not conflict
with previous studies performed on a restricted number of genes [44]. It is well
established that comparative data provides the most unambiguous evidence for se-
lection, but relatively vague assertion on the type of selection and if the selection
is currently acting in a population [21]. For such reasons the connection with pop-
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ulation genetic data is needed. Further studies, mainly focused on this topic, are
required to confirm and understand the relationship that we found.
We used a gene set approach to identify pathways with extraordinary levels of popu-
lation genetic differentiation. The traditional approach used to perform this analysis
is based on the identification of those loci outliers in a given statistic. This approach
has been recently reviewed and its limits explored [24, 45–47]. Interestingly, similar
criticisms are arising on analogous methods used in transcriptomic data analysis. In
this field, alternative approaches, as the “gene set” ones, are gaining increasing in-
terest. Among the tools implementing this approach, Gene Set Enrichment Analysis
[38, 39] is one of the most used [48, 49]. The key idea underlying GSEA is to focus
on gene sets, which are defined as groups of genes sharing common features (e.g. bi-
ological pathways, chromosomal position, etc.). In microarray data analysis, GSEA
aims to determine whether a gene set shows statistically significant, concordant dif-
ferences between two biological states or phenotypes. This method has been tailored
for microarray data, however its use is being explored also in different fields [50, 51].
To the best of our knowledge, the present report is the first attempt to functionally
analyse genes under selective pressure by a gene set statistical approach.
Using very conservative statistics, the GSEA analysis found differential FST values
on seven KEGG pathways, one enriched by low FST genes and six enriched by high
FST genes. However, it is important to note that the discrepancy between the num-
ber of low and high FST pathways is a consequence of the way by which we attributed
FST values to genes rather than underlying evolutionary forces. The only pathway
with decreased degree of differentiation among populations was the “antigen pro-
cessing and presentation” pathway (Figure 2.7). Included in this pathway are genes
involved in the antigen-presenting machinery as (i) the expression of major histo-
compatibility complex (MHC) molecules, (ii) the mechanism of cross-presentation,
and (iii) the interaction of antigen-presenting cells. Opposing views exist concerning
the evolutionary forces that shaped the innate immune system. In particular, the
relative impact of purifying and balancing selection is under discussion [52, 53]. Bar-
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Figure 2.7: Antigen processing and presentation. Genes are colored according
to their FST value.
reiro et al demonstrated that several SNPs of genes related to the immune response
to pathogens showed very high FST values [29]. On the other hand, Akey et al.
reported a four times increase of proteins that perform a defense/immunity function
in the group of the low FST genes [19]. Moreover, low levels of population differen-
tiation have been previously detected at loci that are involved with host-pathogen
responses (HLA class I and class II genes, beta-globin, G6PD, glycophorin A, in-
terleukin 4 receptor-alpha and CCR5 ) [20]. Further evidence arises from the group
of genes that we studied and that were previously described to be under positive
selection. This group of genes, which we found with low FST values, was described
to be enriched for several functions related to immunity and defense [37].
Among the six gene sets enriched by high FST genes, we found the “calcium signal-
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Figure 2.8: Calcium signaling pathway. Genes are colored according to their FST
value.
ing” pathway. Calcium is the most abundant mineral in the body. It is also a highly
versatile intracellular signal that regulates many cellular processes in response to
different external stimuli, as growth factors [54]. We found very high FST values in
three genes belonging to the growth factor stimulated calcium signaling pathway,
namely EGFR, ERBB2, and ERBB4. It is interesting to note that a previous study
from Pickrell et al. found that ERBB4 showed extreme signs of haplotype selec-
tive sweep in non-African populations [30]. The authors suggested that this gene
could affect an unidentified phenotype that experienced a strong recent selection in
non-African population. Our gene set approach seems to confirm this finding and
expands this observation to other members of the ERBB gene family.
The other five high FST pathways are involved in the control of cell shape and mobil-
ity. Among them, four interconnected pathways (“focal adhesion”, “regulation of the
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Figure 2.9: Focal adhesion. Genes are colored according to their FST value.
actin cytoskeleton”, “adherens junction” and “extra cellular matrix receptor interac-
tion”; Figures 2.9, 2.10, 2.11 and 2.12, respectively) govern growth-related processes
and morphogenesis. Morphological traits have been demonstrated to show strong
signature of positive selection [29]. These pathways were found also to be altered in
a mouse model of fetal alcohol syndrome, associated with a low birth-weight pheno-
type [55]. Indeed, human body shape and size varies among populations showing a
correlation with geographic and climate variables [56]. In addition, in the “adherens
junction” pathway, one of the strongest FST values was showed by TCF7L2, the
gene with largest type 2 diabetes effect size found to date [57]. This last finding
is consistent with previous observations [30, 57]. Since it has been demonstrated
that TCF7L2 variants also substantially influence normal birth-weight variations
[58], a complex interplay between pathways that govern growth-related processes
and susceptibility to type 2 diabetes could be hypothesized.
The last high FST pathway, the “axon guidance” (Figure 2.13), is involved in brain
wiring during fetal development and repair throughout life. Axon guidance proteins
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Figure 2.10: Regulation of actin cytoskeleton. Genes are colored according to
their FST value.
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Figure 2.11: Adherens junction. Genes are colored according to their FST value.
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Figure 2.12: ECM receptor interaction. Genes are colored according to their
FST value.
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Figure 2.13: Axon guidance. Genes are colored according to their FST value.
and their relative binding partners have also an emerging role in the pathogenesis
of several neurodegenerative and psychiatric diseases such as schizophrenia [59, 60].
Signature of recent positive selection inferred by identification of selective sweeps in
specific populations was found in genes involved in schizophrenia [61]. Moreover,
population dependent results were obtained when gene-association studies were per-
formed using several high FST genes present in this gene set [62, 63].
It has been suggested that alleles involved in common disease could be targets of se-
lection [15, 56, 64, 65]. The common disease/common variant (CD/CV) hypothesis
proposes that common diseases are usually caused by one or a few common disease
susceptibility alleles. These genetic variants represent ancestral alleles, presumably
under selective pressure, that have become disadvantageous after changes in envi-
ronment and of lifestyle [64, 66, 67]. We found that genes associated with complex
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diseases showed a significant higher mean value of FST , supporting the CD/CV
hypothesis. However, several previous studies of SNPs associated with complex dis-
eases did not find significant evidence of population differentiation [68, 69]. On the
other hand, further studies observed that the distribution of maximum FST was
shifted upward in regions associated with type 2 diabetes mellitus [30]. Moreover
SNPs known to protect against obesity and diabetes showed very high FST values
[29]. Simulation studies also provided support for the CD/CV hypothesis [70].
According to the GAD classification of diseases, we divided the overall group of the
genes associated with complex diseases. Clear differences in FST means among the
various classes were present. In particular, several disease classes, namely “hema-
tological”, “infection”, and “immune”, showed an FST mean value slightly lower
than the mean value of non-associated genes. Nevertheless, the majority of the
classes showed FST mean values to be higher than the non-associated one. Highest
FST values were detected in “pharmacogenomics” and “psychiatric” classes. GAD
classifies in “pharmacogenomics” those diseases related to drug effects. It is well
established that drugs effects are ethnic specific [71]. The GAD “psychiatric” class
includes mental disorders. Why genes that confer susceptibility to mental diseases
are still maintained by natural selection, is an old question which, up to now, is
still unanswered. The compensatory advantage for genes associated to intermedi-
ate phenotypes has been invoked as explanation for this phenomenon, also called
“psychiatric paradox” [72]. Further studies should be performed to determine if the
high level of population differentiation that we found for this disease class could be
related to the psychiatric paradox.
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2.3 Materials and Methods
2.3.1 Data
All analysis are based on the HapMap Public Release #27 (merged II+III) datafiles
(http://www.hapmap.org). We analyzed the data from the CEPH (Utah resi-
dents with ancestry from northern and western Europe; CEU, n = 165), Yoruba in
Ibadan, Nigeria (YRI, n = 167), Han Chinese in Beijing, China (CHB, n = 84)
and Japanese in Tokyo, Japan (JPT, n = 86) samples. We pooled the CHB
and JPT samples to form a single sample. Additional SNP information about
physical positions and SNP-gene association were obtained from dbSNP build 129
(http://www.ncbi.nlm.nih.gov/projects/SNP). In particular, according
to dbSNP classification, we considered all SNPs within 2 kb of a gene (locus region)
as associated to that gene. Data from the International HapMap Project and dbSNP
were merged in a local MySQL database by a set of script from Amigo et al. [73].
When we consider the whole Hap map dataset (autosomes and heterochromosomes)
we analyzed a total of 3, 917, 301 SNPs.
We excluded by this analysis SNPs that were non sampled or non polymorphic in
all the three samples. We excluded also SNPs with a minor allele frequency < 5%
in any of the 3 samples, getting a final SNP sample of 2, 125, 440 SNPs.
2.3.2 Estimation of FST
Fixation index (FST ) was calculated using the unbiased estimator proposed by Weir
and Cockerham [32, 35]. We implemented this calculation in a Perl script available
upon request.
All analyses presented in this work were also performed by using the original FST
estimator proposed by Wright [31] and results are almost identical to that obtained
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by the Weir and Cockerham method. This result is not surprising considering pre-
vious reports [19, 74] and the strong correlation that we found between these two
measures (Spearman’s ρ = 0.97, p< 10−16; see Figure 2.14).
The maximum FST values among those of the SNPs associated to the gene according
to dbSNP (see 2.3.1) was used to assign a FST value to each gene. This approach
is consistent with previously described ones [19, 30]. We studied the correlation
between FST value and gene length and we found that the former have a quite
marginal effect on the latter (r2 = 0.2).
Figure 2.14: Correlation between Wright’s and Weir and Cockerham’s es-
timators for FST . Red line represent the diagonal.
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2.3.3 Statistical Analysis
SNPs FST values are not normally distributed across chromosomes. Thus to detect
differences among medians FST values of chromosomes we used the non-parametric
Kruskal-Wallis test. Conversely, FST values of genes are normally distributed (Kolmogorov-
Smirnov/Lilliefor test, p< 0.001) thus comparison among these values were per-
formed by using parametric tests (ANOVA and t-test).
All statistical analyses were performed with R ver. 2.9 (R Foundation for Sta-
tistical Computing, Vienna, Austria; http://www.r-project.org/). Non-
randomness of data was assessed by using a Ljung-Box test (R function “Box.test”).
We calculated the autocorrelation of each chromosome which can be seen as the
mean correlation of all pairs of FST values separated by a fixed number of values (R
function “acf”).
“Positively Selected Genes” (database “hg18”, table “mammalPsg”) in UCSD Genome
browser (http://genome.ucsc.edu). This list was produced by a genome wide
scan in six mammalian genomes performed by Kosiol et al. [37]. In particular they
identified (i) 400 genes with strong evidence of positive selection across species, (ii)
144 genes with strong evidence of positive selection in one or more branches, (iii)
3705 genes with weak evidence of positive selection on one or more branches, and
(iv) 12280 (orthologs) genes with no significant evidence of positive selection. We
pooled first and second group into a single “strong evidence of positive selection”
group. Differences among groups were evaluated by ANOVA with Bonferroni post-
hoc calculation.
Genes associated with complex diseases were obtained from the Genetic Association
Database (GAD; October 1 2007 update; http://geneticassociationdb.
nih.gov). We only kept genes with positive evidence of association, for a total of
1789 genes. According to GAD, these genes are divided into 15 classes of diseases.
We excluded from the analysis four diseases classes (Other, Unknown, Mitochon-
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drial and Normal variations) because they were not informative. Differences among
groups were evaluated by a t-test and a resampling approach. In particular, we used
a Moving Block Bootstrap (MBB) strategy [75]. Briefly, (i) we resampled 10000
times 1789 set of adjacent SNPs {ni}j with i = 1, . . . , 1789 and j = 1, . . . , 10000
and with each set ni having the same number of SNPs as the i-th GAD associated
gene; (ii) for each resample, we computed the FST of each set ni according to our
method (the maximum FST values among those of the SNPs in the set); then, (iii)
we computed the mean FST value of each resample j obtaining a distribution to
which compare the mean FST value of the GAD associated genes.
2.3.4 Functional Analysis
We used Gene Set Enrichment Analysis (GSEA) 2.0 [76] to detect KEGG pathways
enriched by genes with low or high values of FST . We provided GSEA, by its
“Preranked” feature, with a list L of genes ranked according to their FST value.
Given an a priori defined set of genes S representing a pathway (e.g., genes encoding
products in a metabolic pathway), the goal of GSEA is to find out whether the
members of S are randomly distributed throughout L or mainly found at the top or
bottom (i.e. being “enriched”). Since GSEA preferably expect the values to rank
for (in our case FST ) to vary from negative to positive values, we linear shifted these
values to get vanishing mean.
We explored the enrichment of KEGG pathways included in the software. For each
pathway a False Discovery Rate (FDR) is computed, representing the statistical
significance of the enrichment. For experimental conditions similar to the ours,
GSEA user’s guide suggests a threshold of significance FDR ≤ 0.05. Because of the
exploratory nature of this study, we used a more conservative threshold of signifi-
cance (FDR ≤ 0.01). Overlap among pathways was examined by the “Leading edge




Adaptation to latitude: a possible
model for schizophrenia
Among the environmental factors that strongly influenced our evolutionary history,
geographical latitude deserves particular attention. Latitude, indeed, severely affects
many natural phenomena such as climate, flora and fauna, light-dark cycle, and all
of them, in turn, have an impact on many aspects of our life. For sake of brevity
hereafter we refer to all these phenomena simply as “latitude”.
Genetic traits following a latitudinal gradient have been observed for several poly-
morphisms in humans as well as in natural populations of model organisms like
Drosophila and Arabidopsis thaliana [77–80]. The best known example of this kind
of spatial variation in Homo Sapiens is skin pigmentation. The clinal gradation
of skin colouration is correlated with UV radiation levels and represents a compro-
mising solution to the conflicting physiological requirements of photoprotection and
vitamin D UV-dependent synthesis [81]. The latter is very important since vitamin
D is involved in many health outcomes (e.g. cardiovascular diseases, rickets, pelvic
deformities, infections, etc.).
A possible influence of latitude on the circadian phenotype has also been suggested
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[82, 83]. Circadian rhythm is a ubiquitous feature of living systems. Daylight hours
vary with latitude and seasons therefore adaptability of circadian clocks is of fun-
damental importance for the adaptation of organisms to the alternating light/dark
cycles.
Another example of spatial variation is human body size and shape. These pheno-
types show a correlation with climate (that in turn has a strong relationship with
latitude) suggesting also for humans the adaptation to the classical ecological rules
that individuals living in colder regions are bulkier and have shorter limb lengths
[84, 85].
Nevertheless, it is also possible that an allelic variant increasing the fitness of indi-
viduals at particular latitudes will no longer be advantageous or even increase the
risk for some pathologies at different latitudes. In particular, several diseases show
latitudinal clinals. A well known example regards sodium homeostasis. It have been
postulated that in hot climate regions, genetic variants inducing enhanced sodium
retention were positively selected. This adaptive process would allow a proper vas-
cular tone and salt storage in conditions of excessive sweating. These same variants,
when carried by individuals migrated in colder climates (i.e. African American),
would increase the risk for sodium retention-related hypertension [86]. Supporting
this hypothesis, several studies reported a strong correlation between latitude and
the frequencies of hypertension susceptibility variants [86, 87].
In addition, there is growing evidence supporting the idea that these diseases are
frequently due to a negative by-product of adaptive changes during human evolution
[61]. This is the case when natural selection favours a vital phenotype at the price
of predisposing to some other pathology that, for example, do not directly affect
the reproduction or are characterized by a late onset-age. Indeed, contrasting forces
often affect the outcome of natural selection. For instance, depigmentation is crucial
for vitamin D synthesis at higher latitudes but it also exposes a higher risk for
skin cancer. As most individuals do not develop cancer until they are past their
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reproductive age, from an evolutionary point of view, skin cancer represents a less
powerful selective force than vitamin D availability in serum [88].
Many other common diseases like different types of cancer, dismetabolic conditions,
schizophrenia, Parkinson’s disease, etc. have an incidence following a latitudinal
gradient [56, 89–91]. However, the relative importance of variation of environmental
exposures or genetic predisposition is not yet fully defined. In some cases, a genetic
adaptation has been suggested [56, 61], even if the direct target of this process is
often unclear.
In this work, we investigated the latitude-driven adaptation phenomena, for the first
time, on a wide genomic scale. In particular, we selected a set of SNPs and genes
showing signs of latitude-dependent population differentiation, and by a biological
characterization of the genes, we found enrichment for neural-related processes. In
light of this result, we investigated whether genes associated to pathological phe-
notypes, namely psychiatric and neurological diseases, were enriched for Latitude-
Related Genes (LRGs). Remarkably, we found a strong enrichment of LRGs in the
set of genes associated with schizophrenia. In an attempt to try to explain this
possible link between latitude and schizophrenia, we investigated their association
with vitamin D, which had been previously associated, separately, to both of them.
Our findings suggest a molecular link among latitude, schizophrenia and vitamin D.
1
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A set of SNPs showing high levels of latitude-dependent population differentiation
was selected by using a two-step approach. Our starting point consists of geno-
1The results presented in this chapter are published in: Amato R, Pinelli M, Monticelli A, Miele G
and Cocozza S. (2010) Schizophrenia and Vitamin D Related Genes Could Have Been Subject
to Latitude-driven Adaptation. BMC evolutionary biology 10: 351
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type data concerning about 660, 000 SNP loci of 938 unrelated individuals from 51
populations of the Human Genome Diversity Panel [42].
The first step was the estimation of the population differentiation level of each SNP.
After the exclusion for minor allele frequency and for SNPs falling in intergenic
regions, we obtained a set of 224, 501 SNPs. For all of them we calculated FST
according to the Weir and Cockerham estimator [35], and to select SNPs with high
levels of population differentiation, we extracted those at the top of the empirical
distribution of FST values. Because of the differences existing between the distri-
bution of FST values for autosomic and X-linked SNPs 2.1, these two sets were
handled separately. In particular, we selected 22, 132 autosomic and 459 X-linked
SNPs falling in the top 10% of their own distributions (namely with FST value
greater than 0.153 and 0.262, respectively).
In the second step, we computed for each SNP the absolute value of correlation
between the frequency of the ancestral allele in the 51 populations and the abso-
lute value of geographical latitude of the population location. We again handled
the distributions of correlation values of autosomic and X-linked SNPs separately
because of their differences. Moreover, since population sizes were very different, we
computed the correlation by taking into account the number of individuals in each
population. We selected the autosomic and X-linked SNPs with absolute value of
correlation greater than 0.567 and 0.575 respectively, corresponding to the highest
10% of their respective distributions. We finally obtained two sets of 2193 autosomic
and 46 X-linked SNPs corresponding to 1307 and 29 unique genes. Hereafter, we de-
note by LRGs (Latitude-Related Genes) this set of genes whose SNPs showed both
high FST (mean = 0.230) and high latitude correlation (mean = 0.616) values.
High FST values can be produced both by selection and by demography. The effect
of population histories is potentially the major confounding factor in the interpre-
tation of genetic differences among populations. We tried to estimate the extent of
population differentiation that could be ascribed to selection following the approach
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proposed by Barreiro et al. [29]. To achieve this goal, in their paper Barreiro and
colleagues used a genome-wide approach analyzing both genic and non-genic SNPs.
The main difference between ours and BarreiroO˜s approach is that, in our study,
we considered intragenic SNPs only, since we were focused on functional analysis at
a gene level. In Figure 3.1 we report the proportion in the set of LRGs of SNPs
according to their classes (dbSNP classification). The intronic set does not show
any significant variation with respect to the expected 1% (red line). This value
represents the expected ratio between the number of LRGs SNPs and the number
of all the intragenic SNPs (10% of 10%), under neutral hypothesis. Conversely,
non-synonymous SNP class shows an enrichment of about 30% (p = 0.016; Fisher’s
exact test). This kind of enrichment has been interpreted by Barreiro and colleagues
as a signature of selection.
As a further test for the procedure, we chose a well-known latitude dependent phe-
nomenon such as skin pigmentation and we checked whether LRGs were statistically
overrepresented in the set of genes associated to this phenotype. As expected a sig-
nificant enrichment was found (7 out of 24 genes in common, Fisher’s exact test
p-value 0.0003).
To characterize the set of LRGs we used two methods, tissue localization and func-
tional characterization. Firstly, we explored the tissue localization of proteins en-
coded by these genes. To achieve this, we used the Database for Annotation, Vi-
sualization and Integrated Discovery (DAVID) focusing on the “Uniprot Tissue”
list, a curated list of localization based on literature mining. We found that genes
expressed in brain and brain-related tissues were significantly enriched in LRGs,
accounting for more than a half of them (Table 3.1).
LRGs were also functionally characterized by looking for overrepresentation of Gene
Ontology (GO) annotation terms [92]. Because of the high redundancy of GO, we
used the Model-based Gene-Set Analysis (MGSA) method included in Ontologizer
2.0 [93, 94]. This promising and novel approach analyses all categories together by
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Figure 3.1: Proportion, in the set of LRGs, of SNPs according to their
dbSNP classification. Red line represents the expected ratio between
the number of LRGs SNPs and the number of all the intragenic SNPs (1%
= 10% of 10%), under neutral hypothesis. Error bars represent the 95%
confidence level of the observed proportion obtained in the analytical
way by using the Wilson score interval method.
Tissue LRGs count (%) p-value
Brain 683 (56.6%) 3× 10−18
Amygdale 112 (9.3%) 8× 10−6
Thalamus 76 (6.3%) 1.4× 10−4
Table 3.1: Enrichment in tissue for LRGs computed using the DAVID’s
Uniprot Tissue category. For each tissue is reported the number
and the percentage of LRGs expressed in the tissue and the significance
(Fisher’s exact test, Bonferroni adjusted) of that enrichment.
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Table 3.2: Enrichment for GO terms by LRGs. For each term is reported the
sub ontology to whom it belongs (CC: cellular component; BP: biological
process), the mean, minimum and maximum marginal posterior probabil-
ity of being involved (among 20 runs) and the number of genes annotated
in the list of LRGs and in total.
embedding them in a Bayesian network. Differently from other methods, it provides
for each term a marginal posterior probability that reflects a measure of certainty in
its involvement in the process. Following the authors’ recommendation, we repeated
the analysis 20 times in order to see whether the reported marginal probabilities
of the top terms fluctuated. We found that two terms out of the three showing a
posterior probability above 0.5 consistently among the 20 runs were related to neural
processes (Table 3.2).
All these results suggested a further investigation about a possible relationship be-
tween LRGs and genes involved in neuropsychiatric diseases related with latitude.
Indeed, several neurological diseases were previously described to have a latitude-
shaped incidence and/or prevalence [89, 91, 95]. To perform this task we compared
the list of LRGs with publicly available collections of genes involved in schizophre-
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Schizophrenia 85 885 4× 10−6 1.6× 10−5
Parkinson’s disease 40 490 0.021 0.084
Multiple sclerosis 16 178 0.058 0.232
Alzheimer’s disease 45 618 0.075 0.3
Table 3.3: Enrichment of neuropsychiatric diseases lists by LRGs. For each
disease genes list, it is reported the number of LRGs present, the total
size of the list and the significance of the overlap (Fisher’s exact test and
Bonferroni’s correction.
nia, multiple sclerosis, Parkinson’s and Alzheimer’s disease [60, 96–98]. While there
is a weak or non significant overlap with genes related to multiple sclerosis, Parkin-
son’s and Alzheimer’s disease, we found a significant enrichment of 85 LRGs in genes
related to schizophrenia (Fisher’s exact test, Bonferroni adjusted p-value 1.6×10−5;
Table 3.3 and Figure 3.2).
We explored if the enrichment found for schizophrenia with the used list was also
present in pruned sub-lists. Four different lists were used and all fairly support the
presence of a relationship between latitude and schizophrenia.
“Association”: It was obtained from the SchiZophreniaGene (SZGene) database,
cleaning data according to a risk-allele evaluation pipeline developed by Sun et
al. [99]. According to this meta-analysis, 278 protein-coding genes were selected
having significant p-values using a combined OR method or at least one positive
association result in publication. In this gene set we found an enrichment of 27
LRGs (p = 0.0068).
“Core”: It contains genes that have been manually collected to include those that
have been commonly considered as candidate genes in expert review or had signif-
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Figure 3.2: Overlaps among latitude, vitamin D and schizophrenia related
genes. In each circle is reported the number of genes present in the list.
For the two-way intersections is reported the size and the significance of
the overlap (Fisher’s exact test).
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icant results in the meta-analysis of association studies. Ross et al. [100] reviewed
the evidence in four domains (association with schizophrenia, linkage to gene locus,
biological plausibility, and altered expression in schizophrenia) and suggested 19
genes being candidates. They also included 27 genes with significant meta-analysis
results performed by the SchizophreniaGene team. The genes were selected by hav-
ing a nominally significant summary OR in all ethnic groups or Caucasian samples.
After removing redundancy, the core gene set contains 38 genes. In this set we found
an enrichment of 7 LRGs (p = 0.0059).
“75 genes by COR”: This list contains 75 genes that were prioritized by ranking
about 500 genes from more than 2000 association studies [99]. This list shows an
enrichment of 11 LRGs (p = 0.0041).
“173 by Ng et al.”: This list contains 173 genes and it is based on genetic studies for
schizophrenia from four major categories: association studies, linkage analyses, gene
expression, and literature search. Genes in these data sets are initially scored by
category-specific scoring methods. Then, an optimal weight matrix is searched by a
two-step procedure (core genes and unbiased P values in independent genome-wide
association studies). Finally, genes are prioritized by their combined scores using the
optimal weight matrix. This set shows an enrichment of 19 LRGs (p = 0.0061).
We then investigated for possible latitude-dependent biological mechanisms linking
latitude to neural development. An important factor hypothesized to be both lat-
itude dependent and neural development-related is vitamin D. We checked for an
enrichment of LRGs in Vitamin D Related (VDR) genes by manually creating a list
of 943 genes that broadly comprised the most important processes in which it is
involved, since a comprehensive list is not yet present in the literature. To achieve
this, we merged: a list of 6 genes implied in the metabolism of vitamin D obtained
from Reactome, a list of 26 genes in the pathway of the control of the expression
by vitamin D receptor from Biocarta and a list of 911 genes from a large-scale
identification of 1,25(OH)2D3 target genes by Wang and colleagues [101].
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We computed the overlap between LRGs and VDR genes and found a significant
overlap of 97 genes (p-value 3.5× 10−8, Fisher’s exact test; Figure 3.2). This result
suggests that VDR genes show signature of latitude-dependent population differen-
tiation. Also the overlap of 70 genes between VDR and schizophrenia related genes
was significant (p-value 1.4 × 10−6, Fisher’s exact test; Figure 3.2) confirming the
role of vitamin D in schizophrenia pathogenesis.
Finally, we found 9 genes (SMARCA2, MITF, DLGAP1, MAGI1, IL4R, NTRK3,
RUNX1, PPP3CA and INPP4B) in common among those ones related to latitude,
vitamin D and schizophrenia (Figure 3.2). We checked whether or not in these 9
genes belonged SNPs, selected by our procedure, that were previously studied in
relationship to either schizophrenia or vitamin D related phenotypes. One SNP re-
sulted from the analysis, rs3793490 (FST = 0.202, correlation = 0.626), an intronic
SNP of the SMARCA2 gene. In Figure 3.3 is reported its alleles geographic distri-
bution (A) and the values of cross-Population Extended Haplotype Homozygosity
(XP-EHH) (B) of the genomic region. This test detects alleles that have risen to
high frequency rapidly, enough that long-range association with nearby polymor-
phisms (the long-range haplotype) have not been eroded by recombination. The
analysis showed a strong sign of recent selective pressure.
3.2 Discussion
Many natural phenomena are directly or indirectly related to latitude. Living at
different latitudes has consequences in being generally exposed to different climates,
diets, light/dark cycles, etc. Therefore, it is reasonable to presume that exposure of
individuals to different latitudes could have shaped genetic background as a result of
the adaptation process. Indeed, relationships between allelic frequencies of specific
genes and latitude have been identified in plants [102–104] and animals [105, 106].
Previous studies in humans, at specific loci, have found evidence of correlation be-
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Figure 3.3: Alleles geographic distribution (A) and cross-population ex-
tended haplotype homozygosity (B) for the SNP rs3793490.
Images were readapted from the “HGDP Selection Browser”. The red
line marks the SNP’s position inside the SMARCA2 gene region.
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tween allelic frequencies and latitude of sampled populations. For example allelic
frequencies of a genetic polymorphism in the prion gene PRNP showed a clear cor-
relation with the latitude within Europe [107] and one in the ACP1 worldwide
[108].
To explore possible genetic adaptations to latitude, within this work we defined
a set of latitude-related genes (LRGs) following a two step approach. Firstly, we
identified SNPs with a high level of population differentiation (FST ) with the aim
to enrich for variants under selective pressure. From these we then extracted those
SNPs showing high values of correlation of allelic frequencies with the geographical
latitude. To the best of our knowledge this is the first search at a wide genomic
level for loci showing latitude-dependent populations differentiation.
Both functional characterization and expression localization of LRGs resulted in a
strong enrichment of neural-related processes (Tables 3.1 and 3.2). The relation-
ship between neural development and latitude is partially known. In particular,
there exists evidence of a latitude correlation of some physiological neural-related
phenotypes. It was reported for humans that cranial capacity is different between
populations, probably, as results of adaptation for brain cooling and that the cran-
iofacial diversity results from the tissues of neural crest origin [85]. It is worth
stressing that although population differences are observed in these phenotypes, no
relationship exists with mental functioning. Also, for several pathological neural
phenotypes there has been described previously a relationship with latitude. For
multiple sclerosis and schizophrenia there was a latitudinal variation in incidence
and prevalence [91, 95]. An association between mortality related to Parkinsonism
and birthplace geographical latitude was also found [109].
When we compared the list of LRGs with those containing genes associated to
neurological and psychiatric diseases, we found a vanishing enrichment of LRGs
in genes related to multiple sclerosis, Alzheimer’s and Parkinson’s disease (Table
3.3). This is not surprising. Concerning Alzheimer’s and Parkinson’s diseases, it
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should be noted that the relationships with latitude reported in the literature are
not largely confirmed as in the case of the other two diseases. Multiple sclerosis
has a strong immunity component in the etiology. Since genes involved in immunity
related processes usually exhibit low levels of FST [19] (see also 2.1), they are likely
to be excluded by our procedure, in this way weakening the enrichment.
In contrast, we found a strong significant enrichment of LRGs in genes associated
with schizophrenia (Table 3.3 and Figure 3.2). The correlation of schizophrenia
prevalence with latitude is both large and robust [110]. In previous surveys it was
noted that there is a strong tendency for schizophrenia prevalence to increase with
increasing latitude [91, 111]. The present result also agrees with that obtained in one
of our previous works, based on different data and different statistical approaches.
In this previous study, we explored for signs of natural selection in genes associ-
ated to complex diseases, and the strongest level of population differentiation was
observed in genes associated to psychiatric diseases (see 2.1). In addition, testing
for recent selective sweeps in human populations, Crespi and colleagues found sig-
nificant evidence for adaptive evolution of several genes underlying schizophrenia
[61]. Our results may suggest that a latitude-related adaptation occurred for some
schizophrenia associated genes, but to which extent this phenomenon is related to
the latitude-shaped prevalence of schizophrenia is of course still an open question.
Searching for a mechanism that could connect latitude and schizophrenia at a molec-
ular level, we reasoned that a well-known phenomenon separately linked to both of
them is vitamin D. Indeed, vitamin D is essential for normal growth, calcium absorp-
tion and skeletal development. The cutaneous synthesis of vitamin D is a function of
skin pigmentation and of the solar zenith angle which, in turn, depends on latitude,
season, and time of day [112]. With the same dietary intake, the most important
determinant for vitamin D levels is considered to be where individuals live, because
of the dependence on geographical location of the availability of UV radiation for
vitamin D synthesis. Ancestral populations who migrated out of Africa, moving
from south to north were exposed to less incident sunlight. It is commonly accepted
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that, in these conditions, depigmentation was favored [81]. This adaptation process
was compulsory, since pelvic deformities due to vitamin D deficiency could prevent
normal childbirth, but it is reasonable to suggest that also other molecular mech-
anisms apart from depigmentation could have been subject to selective pressure in
order to increase the levels of vitamin D in the body.
To test this link at a genomic level, we created a hand-curated list of genes that,
at different levels, are related to vitamin D (see 3.1). We found among vitamin D
related genes a significant enrichment for genes latitude-related (Figure 3.2). This
result may suggest that vitamin D related genes could have been subject, at least in
part, to a latitude-dependent adaptation, supporting the hypothesis that selection
also acted on other mechanisms different from depigmentation.
On the other hand, the relationship between vitamin D and schizophrenia is well
established. Vitamin D receptors were found in most tissues other than those clas-
sically involved in the vitamin D action (bone, gut, kidney, etc.). In particular,
receptors for vitamin D are widely distributed in the nervous system and vitamin D
has been recently implicated in brain function [113]. There is growing evidence that
low vitamin D levels adversely impact on brain development [114]. In mice, it has
been suggested that changes in brain development induced by prenatal vitamin D
deficiency lead to specific functional alterations in hippocampal synaptic plasticity
[115]. Also in humans, maternal vitamin D insufficiency has been associated with
childhood rickets and longer term problems including schizophrenia [116]. In addi-
tion, epidemiological data suggest that vitamin D deficiency may be associated with
increased risks of mental health disorders such as schizophrenia [117]. Despite the
consistence of this relationship, to our knowledge studies connecting schizophrenia
and vitamin D at a molecular level are not yet available.
We found a significant overlap of 70 genes between schizophrenia and vitamin D
related genes (Figure 3.2). Our analysis provides the first hint, at a genomic level, of
the existence of a relationship between them. The largest part of vitamin D related
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genes in our list is made by genes differentially expressed in epithelial cells after
treatment with the biological active form of vitamin D [101]. It is therefore possible
that the same genes could be regulated by vitamin D levels also in neurons during
brain development that, in turn, have been associated to schizophrenia [110].
According to our hypothesis that vitamin D could be the link between latitude
and schizophrenia, we focused on the 9 LRGs present in both the lists of vitamin
D and schizophrenia related genes (Figure 3.2). Among these genes, that were
related to schizophrenic phenotypes, several of them were also previously described
in association with bone development. However, no evidence of selective adaptation
was present in the literature until now.
For example, one of these genes is the neurotrophic tyrosine kinase receptor type
3 (NTRK3 ) which encodes a member of the NTRK family. These neurotrophins
(NTs) receptors are best known for their role in the differentiation and survival
of various types of neurons [118]. Gene expression of NTRK3 has been reported
to be reduced in patients with schizophrenia [119, 120]. Furthermore, it has been
suggested that the NTRK3 gene influences hippocampal function and may modify
the risk of schizophrenia [121]. Nevertheless, NTs and their receptors are also pro-
duced by a growing list of non-neuronal cells [122] including osteoblastic cell lines
[123]. NTs receptors were observed in the bone forming area during fracture healing.
NTRK3 was observed in osteoblast like cells and hypertrophic chondrocytes [124].
Another example is PPP3CA (protein phosphatase 3 catalytic subunit alpha iso-
form). This gene, also known as calcineurin A alpha, acts as a calcium-sensor and
regulator of calcium homeostasis. For this reason, it shapes calcium and cyclic AMP
dependent processes like synaptic activity, receptor desensitization, cell survival and
neuroplasticity. Expression of PPP3CA, previously described by microarrays analy-
sis from cortical [125] and rat hippocampus tissues [126], was found down regulated
in schizophrenic anterior temporal lobe [127]. On the other hand, PPP3CA is also
expressed in osteoclasts, playing a role in the regulation of bone resorption and its
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deletion results in osteoporosis [128, 129].
At least in one case, we also found independent evidence of an adaptive process,
reasonably suggesting a molecular mechanism. This is the case of the SMARCA2
(SWI/SNF related, matrix associated, actin dependent regulator of chromatin, sub-
family a, member 2) gene. The protein encoded by SMARCA2 (also known as BRM )
is part of the large ATP-dependent chromatin remodelling complex SNF/SWI, which
is required for transcriptional activation of genes normally repressed by chromatin.
Mammalian SWI/SNF complex actually consists of a small series of compositionally
distinct assemblies distinguished by the presence of alternative subunits. The com-
plexes contain either one of two closely related alternative ATPases: Brahma (BRM
i.e. SMARCA2 ) or Brahma-related gene 1 (BRG1 ). The combinatorial assembly of
these complexes could account for the specificity of their functions in different tis-
sues and development phases. SWI/SNF components and DNA replication-related
factors form, in turn, a human multiprotein complex (WINAC) that directly inter-
acts with vitamin D receptor [130]. WINAC and vitamin D receptor are targeted to
vitamin D responsive promoters in the absence of ligand to both positively and neg-
atively regulated genes. WINAC may rearrange the nucleosome array around the
positive and negative vitamin D responsive elements (VDREs), thereby facilitat-
ing the coregulatory complexes access for further transcription control. Subsequent
binding of coregulators requires ligand binding. Several studies have revealed that
one family of the SWI/SNF complexes based on the BRG1 and BRM ATPases has
particular critical dosage-dependent roles in the development of the nervous system
[131, 132].
One of the five SNPs with the highest levels of both population differentiation and
correlation with latitude that we identified at this locus was rs3793490. In a previous
study this SNP was associated with SMARCA2 expression levels in the human brain
[133]. In particular, the T variant, whose frequency increases in a latitude dependent
way, is associated with low SMARCA2 expression levels. Much evidence suggests
that low levels of SMARCA2 may play a role in the pathophysiology of schizophre-
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nia. SMARCA2 knockout mice showed impaired social interaction and prepulse
inhibition. In the mouse brain, psychotogenic drugs lowered SMARCA2 expres-
sion while antipsychotic drugs increased it [133]. On the other hand, in MC3T3-E1
cell line, deficiency of SMARCA2 results in an accelerated rate of mineralization
with higher levels of expression of osteogenic markers [134]. In addition, the most
prominent phenotype of SMARCA2 null mice is a larger (about 14% more than
normal) body size with a disproportionately increased bone and muscle mass [135].
Putting together all this data seems to suggest that SMARCA2 deficiency is asso-
ciated with different effects on bones and neurons. It is possible to speculate that
a selective pressure could have favoured a haplotype containing the T allele in an
environment with low vitamin D availability, for its positive effect on the bone phe-
notype. In turn, the low SMARCA2 expression levels linked to this variant could
be responsible for the increased risk of schizophrenia. The XP-EHH analysis that
we performed (Figure 3.3) confirms the presence of a strong recent positive selec-
tion in the SMARCA2 locus. Interestingly, the homozygosity geographical pattern
detected by XP-EHH recognises the effect that we found with correlation analysis.
These results agree with a previously described hypothesis of schizophrenia being, at
least partly, a maladaptive by-product of adaptive changes during human evolution
[61].
In Figure 3.2 besides the described overlaps among the lists used, large non-intersecting
areas exist. This can be partially due to technical limitations of our work. Anyway,
these areas of non-intersection were, at least in part, expected. As stated, latitude
acts directly or indirectly, on a wide variety of phenomena, therefore it is expected
that its effects are not limited just to vitamin D and neural development. For similar
reasons, we expected that also the link between latitude and schizophrenia cannot
be completely explained by vitamin D. For example, in the intersection between
LRGs and genes related with schizophrenia there is a gene involved in the circadian
rhythms, TIMELESS.
Circadian rhythm consists of light and dark phases which coincide with the phases
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of the solar day and that is, obviously, correlated with the different photoperiods
existing at different latitudes. TIMELESS is required for normal progression of
S-phase and is involved in the circadian rhythm autoregulatory loop. Associations
between circadian gene polymorphisms, including TIMELESS, and some mental
disorders have been found, including schizophrenia [136]. In addition, expression
of TIMELESS was investigated in the pitcher-plant mosquito, Wyeomyia smithii,
and was found to vary with latitude of origin. This suggests that other mechanisms
should be taken into account [137].
It is worth stressing that this work represents just an initial exploration of this com-
plex problem and can suffer from some limitations. The first aspect to take into
account is the arbitrary choice of the thresholds used as inclusion criteria in the list
of LRGs. However, it should be underlined that our aim was just to obtain a list
enriched for genes showing both high levels of population differentiation and correla-
tion with latitude. Another important aspect is that the largest part of our analysis
is based on hand-curated lists. Nevertheless, it should be noted that these lists are
widely used [138, 139]. The only exception is the list of vitamin D related genes
that we had to build ex novo since no others were present in literature. In addi-
tion, a cause-effect relationship can never be conclusively established based only on
a reciprocal enrichment between sets of genes. Moreover, alternative explanations
of the observed enrichments can be imagined. For example, we cannot exclude the
presence of an unknown common factor, different from vitamin D, linking together
schizophrenia and latitude. A further limit of our approach concerns the gene level
analysis. In fact, focusing on genes rather than on SNPs, does not allow to conclu-
sively assess whether variants related to latitude coincide with those involved in the
studied phenotypes. In other words, even if a gene is associated to both latitude
adaptation and schizophrenia, we cannot exclude that this is due to functionally
independent variants. For this reason our conclusions should be corroborated by
further and more detailed studies. Finally, we are aware that population differenti-
ation is influenced by demographic history and thus it cannot be straightforwardly
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interpreted as a sign of natural selection. Some approaches have been proposed to
evaluate the impact of natural selection on population differentiation. Under the as-
sumption of neutrality, any set of SNPs, even if classified according to their physical
location and functional impact, should show the same degree of population differen-
tiation. According to Barreiro and colleagues, any deviation from this expectation
should be attributable to selection [29]. In particular, the authors observed that
variants leading to amino-acid changes (non-synonymous mutations) are overrepre-
sented among SNPs showing high level of FST . They interpreted this excess as the
result from the action of natural selection. We used a similar approach to analyse
our data. We found an excess of non-synonymous polymorphisms in LRGs. This
result seems to suggest the appreciable presence of genes under selective pressure in
LRGs.
Recently, an international team of researchers presented the first detailed analysis of
the draft sequence of the Neanderthals’ genome [140]. In particular, they showed the
presence of interbreeding between Neanderthals and Homo Sapiens occurred after
the Out-of-Africa migration. Affecting mainly the non-African populations, this
genetic flow could mimic a latitudinal effect on the Africa-Europe axis and therefore
potentially influences our conclusions. First of all, LRGs are selected according to
a worldwide latitude correlation, which is only partially due to the Africa-Europe
axis. This is the case, for example, of the rs3793490 SNP (Figure 3.3) where it is
also clear a latitudinal effect out of this axis. In addition, Europeans and Asians
share only 1% to 4% of their nuclear DNA with Neanderthals suggesting a limited
impact, if any, on our conclusions. Finally, we observed that approximately 10%
of LRGs are present in the list of genes that Green et al. showed to have evolved
recently in our lineage after we split from Neanderthals, and thus, at least in these
cases, we can confidently exclude the influence of interbreeding.
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3.3 Materials and Methods
3.3.1 Data
The whole analysis is based on genotypes data of 660, 918 single-nucleotide poly-
morphisms (SNPs) in samples from the Human Genome Diversity Panel (HGDP-
CEPH), which represents 938 unrelated individuals from 51 populations from sub-
Saharan Africa, North Africa, Europe, the Middle East, South/Central Asia, East
Asia, Oceania, and the Americas. We removed the two small heterogeneous South-
ern Bantu populations as in [141]. Genotypic data was retrieved from http://
hagsc.org/hgdp/ [42] while geographical information was obtained from http:
//www.cephb.fr/en/hgdp/.
For all the SNPs, we computed the allelic frequencies within each population by
using the R package “genetics” version 1.3.4. Additional SNP information about
physical positions and SNP-gene mapping were obtained from dbSNP build 129
http://www.ncbi.nlm.nih.gov/projects/SNP. Data from the HGDP-CEPH
project and dbSNP were merged in a local MySQL database.
After excluding SNPs with minor allele frequencies less than 5% in all of the popu-
lations, we obtained a set of 655, 810 SNPs. Since we were interested in performing
this study at a gene level, we retained only intragenic SNPs obtaining a final set of
224, 501 SNPs. In particular, we considered all SNPs within 2 kb of a gene, accord-
ing to dbSNP classification. We also excluded the Y-linked SNPs because of scarce
numbers.
Genes underlying skin pigmentation were obtained from a study by Myles and col-
leagues [142]. Genes related to neuropsychiatric diseases were obtained from a set of
publicly available comprehensive, uniform and regularly updated database of genes
considered involved in schizophrenia, multiple sclerosis, Parkinson’s and Alzheimer’s
disease [60, 96–98]. These databases collect genes related to these phenotypes re-
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sulting from different approaches (association, genome-wide, candidate, etc.). We
used the January 30th 2010 update of these databases, containing 892, 197, 511 and
622 genes, respectively. The list of vitamin D related genes was manually created
by merging three different lists of genes related in different ways to vitamin D. The
first list is the “Vitamin D (calciferol) metabolism” pathway by Reactome (RE-
ACT 13523.2). The second one was extracted from the Biocarta’s pathway “Con-
trol of the expression by vitamin D receptor” (h vdrPathway) as present on the
Cancer Genome Anatomy Project http://cgap.nci.nih.gov/. Finally, can-
didate transcriptional target genes of vitamin D were obtained from a set of genes
differentially expressed in SCC25 cells treated with 1,25(OH)2D3 by a genome-wide
microarray analysis [101].
A common problem in using lists of genes is that different types of gene identifiers are
used. The effect is that usually only part of the genes is recognized. Therefore, each
tool that we used lost a variable number of genes during the analyses. Nevertheless,
to obtain the best performances from each tool we decided to provide them with the
whole lists. In particular, DAVID recognized 1207 identifiers and MGSA recognized
1101 ids. In addition, overlaps between lists of genes were computed by using
MatchMiner web tool, which also takes into account gene aliases and/or different
types of gene identifiers [143]. This tool recognized 885 schizophrenia, 178 multiple
sclerosis, 490 Parkinson’s disease, 618 Alzheimer’s disease and 1254 latitude related
genes.
3.3.2 Statistical analysis
For all SNPs we calculated the fixation index (FST ) according to the Weir and Cock-
erham estimator [35] using the previously developed Perl script (see 3.3). We then
computed the absolute value of the correlation between the frequency in each popu-
lation of the ancestral allele and the absolute value of the latitude of the population
weighted by its sample size. This was to avoid the overweighting of allelic frequen-
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cies inside small populations and was implemented simply by using the weighted
mean, standard deviation and covariance.
Statistical significance of overlaps was estimated by using Fisher’s exact test, consid-
ering 21463 genes (number of distinct gene symbols present in the “refGene” track
of UCSC Genome Browser) as background population. All statistical analyses were
carried out with R ver. 2.10.1 [144]. The whole study was conducted considering a
p-value of 0.001 as statistical significance threshold.
To check for a potential bias toward larger genes (since they can contain more
genotyped SNPs), we applied the non -parametric Mann-Whitney test to compare
the difference among the lengths of LRGs with respect to the remaining genes in
the “refGene” track of UCSC Genome Browser. There is no statistical evidence for
a difference (p = 0.07), with median length of LRGs slightly smaller than median
of the others.
3.3.3 Biological characterization
The analysis of gene expression localization was performed by using the Database for
Annotation, Visualization and Integrated Discovery (DAVID) v6.7 and the “UP TISSUE”
category [145, 146]. The “Uniprot tissue” (UP TISSUE) list is based on literature
mining and reports for each gene in which tissues it has been found to be expressed,
by using a curated vocabulary.
Overrepresentation of GO terms was assessed by using Ontologizer 2.0 and the
Model-based Gene Set Analysis (MGSA) method. The idea behind this approach
is to estimate the marginal posterior probability of a term being enriched by using
a Bayesian Network. The greater probability for a GO term being near to 1, the
higher is the certainty of its involvement in the process. All parameters were left
to “auto”, allowing the system to automatically estimate the optimal a priori prob-
abilities and the false positive and false negative rates. Probabilities are estimated
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by MGSA using 107 Markov-Chain Monte Carlo (MCMC) steps. Since MCMC is
not guaranteed to converge in any a priori defined number of steps, we repeated the
analysis 20 times and retained only terms having a marginal posterior probability





In human history, infections have been a powerful selective pressure [147]. After
the human species originated in sub-Saharan Africa more than 100 kya, it spread
much of the globe. In this journey, humans were exposed to new pathogens that
challenged their immune system; as a result, genetic variants conferring resistance to
infections would have been preferentially selected. However, several genetic variants
that protect against infections may also predispose to autoimmune diseases (ADs)
in contemporary populations (e.g., alleles of solute carrier family 11 member 1,
SLC11A1 ) gene that protect against tuberculosis predispose to rheumatoid arthritis
(RA) and type 1 diabetes (T1D) [148, 149]. Consequently, genetic perturbations of
the immune system that occurred as a result of adaptations to pathogen exposure
may involve variation that influences risk to ADs, and might also be responsible for
population differences in AD prevalence. 1
1The manuscript based on the results presented in this chapter is currently in preparation. This
project was developed at the University of Chicago under the supervision of Anna Di Rienzo.
Gorka Alkorta-Aranburu performed all the experiments and was responsible for all the biological
contents. David Witonsky actively contributed in the preliminary phases and during the whole
project.
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Chapter 4 Evolutionary forces shaping autoimmunity
Common disorders of the immune response and AD in particular. The purpose of
the body’s immune system is to fight infectious agents, such as viruses or bacteria.
However, several things can go wrong with the immune system. Disorders of the
immune system can be broken down into four main categories: immunodeficiency
disorders (when a part of the immune system is not present or is not working prop-
erly), cancers of the immune system, allergic disorders (in which the immune system
overreacts in response to an antigen, for example, asthma, eczema and allergies), and
ADs (in which the body’s own immune system attacks its own tissue). Normally, AD
is prevented by a self-tolerance mechanism, which depends on a succession of control
layers that operate at different sites and stages of development. Interestingly, genetic
variation in tolerance control layer genes has been associated with autoimmunity:
(1) genes that affect autoantigen availability and clearance (e.g., component C3,
C1q, C2, and C4 of the complement pathway, Mannan-binding lectin, autoimmune
regulator AIRE ); (2) genes that affect apoptosis (e.g., Fas and FasL mutations in
autoimmune lymphoproliferative syndrome ALPS ); (3) genes that affect signaling
threshold (for example decreasing receptor sensitivity in the thymus can fail to nega-
tively select autoreactive cells, and increasing sensitivity in the periphery can cause
an exaggerated immune response causing autoimmunity; and (4) genes affecting
co-stimulatory molecules, for instance, citotoxic T lymphocyte-associated antigen 4
(CTLA4 ). CTL4 is a member of the CD28 family that binds to CD80 and CD86
and transduces an inhibitory signal to T cells. When the gene for CTLA4 is knocked
out in mice, it results in a severe and lethal autoimmune syndrome [150]. Even in
humans, CTLA4 variation, together with protein tyrosine phosphatase (PTPN22 )
and TNF-α variation, has been associated with different ADs indicating that au-
toimmune phenotypes could represent pleiotropic outcomes of non-specific diseases’
genes that underline similar immunogenetic mechanisms [151].
Still, the strongest influence on susceptibility is the major histocompatibility com-
plex (MHC), in particular human leukocyte antigens (HLA) [151]. In addition to
genetics, environmental factors also influence AD risk. Certain drugs elicit autoim-
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munity as a side-effect (e.g., procainamide induces lupus-like autoantibodies [152])
and toxins can also cause autoimmunity (e.g., heavy metals such us gold or mer-
cury [153]). Infections are also associated with the onset of AD. Infections destruct
tissues, so inflammatory mediators (e.g., cytokines and chemokines) are released,
which can activate self-reactive lymphocytes. Many pathogens can secret their own
cytokines or prevent lymphocyte apoptosis [154, 155]. Even in healthy individuals
isolated breakdowns of one or more layers can be detected. However, ADs only
develop when enough safe guards are overcome to lead to a sustained and persistent
immune response against self, including the generation of effectors of tissue destruc-
tion. This is because each tolerance layer is partly effective in preventing anti-self
responses, and all of them together provide efficient protection against autoimmunity
without inhibiting the immune system’s ability to fight against pathogens. Conse-
quently, some degree of autoimmunity can be thought of as the evolutionary price
of being able to make effective responses against pathogens.
The identification of genes that promote autoimmunity might help in AD diagnosis,
prognosis, identifying risk individuals who could benefit from medical intervention
before disease and suggesting new therapeutic strategies. Recent advances, such as
the International HapMap project [34, 156] and high throughput genotyping plat-
forms (e.g., Illumina, and Affymetrix) offer new opportunities to rapidly screen
common genetic variation across the genome, making GWASs powerful and ap-
proachable. As a result of these advances, several GWASs have identified a large
number of common AD risk variants (ADRVs) without prior knowledge of position
or function. At the same time, methods to scan the human genome for selection sig-
nals have been developed and applied to large-scale data sets such as those from the
HapMap project [25, 27, 157]. Interestingly, several of these studies found signals of
selection in genes involved in the immune response, further supporting the notion
that pathogens have exerted strong selective pressures on the human genome. For
example, using SNP data, Voight et al. [25] detected a significant excess of MCH-
1 mediated immunity genes with evidence for partial sweeps in the CEU (CEPH
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European population) (p-value < 0.0001), but not in the YRI (Yoruba population,
Ibadan, Nigeria) (p-value = 0.002) or the ASN (the Han Chinese and Japanese
populations) populations. In addition, Sabeti et al. [27] also reported that like-
glycosyltransferase (LARGE ) and dystrophin (DMD) genes, which are both related
to infection by the Lassa virus, are suspected to be under positive natural selection
in the YRI.
4.0.4 Major transitions in pathogen exposure during human
history.
Many significant human diseases are thought to have arisen with the introduction
of agriculture. Before the Neolithic period, the main form of human subsistence was
hunting and gathering (HG), which was characterized by small and scattered popula-
tions. Approximately 10,000 years ago, however, with the introduction of agriculture
and animal husbandry, humans transitioned to a sedentary agricultural (AG) subsis-
tence, population size/density increased, and humans became attractive pathogen
hosts because large populations in small areas maximize the chance of transmission
between longer-lived barriers. Therefore, the human population growth during the
Neolithic created the conditions that favored the emergence of pathogens that spe-
cialize in human hosts [158]. In addition, many pathogens became endemic. As
most individuals reaching reproductive age were exposed to pathogens in early life
and acquired resistance, variants conferring resistance were preferentially transmit-
ted to the next generation and, therefore, were selectively advantageous. Nutritional
deficiency reinforced this selection. First, since AGs rely on 1 or 3 crops, not having
back-up crops, starvation, mortality and disruption of fertility cycles are expected
[159]. Second, in order for mothers to quickly return to reproductive readiness, AG
infants were weaned earlier; in addition, the low-protein and high-carbohydrate diet
typical of the agricultural subsistence made these infants more prone to diarrhea and
infections. This high AG infant mortality was balanced by reducing birth spacing,
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which worsens infant and mother’s nutrition and health [159].
In addition to subsistence, other features of the physical environment are known
to be important determinants of pathogen load and diversity. It is well established
that plant and animal species diversity is strongly correlated with distance from the
equator. It was recently shown that this correlation holds for pathogens, and that it
is mainly due to climatic factors [160]. This raises the question of whether the main
shift in the selective pressures acting on ADRVs occurred (1) when humans changed
the environment with the introduction of agriculture, (2) when climate changed, for
instance, during the last glaciations and humans moved to higher latitudes, or (3)
when humans became exposed to different climates and environments as a result of
the exodus from Africa. The first two scenarios are not distinguishable in terms of
the timing of selection as both transitions occurred within a relatively recent window
of time (the last 14 kya). The third scenario, however, is expected to result in older
selection signals compared to the other two. Therefore, the end of the Ice Age
(coupled with the advanced agriculture) and the dispersal out of Africa represent
two major moments when genetic variants affecting autoimmunity could have been
selected.
To understand the evolutionary forces shaping autoimmunity, a population genet-
ics approach is proposed. When a genetic variant is advantageous, chromosomes
carrying it quickly increase in frequency while chromosomes that do not carry the
selected variant are lost. This process creates a signature in the patterns of neutral
variation tightly linked to the selected site, which may affect multiple aspects of ge-
netic variation (i.e., nucleotide diversity, variation frequency spectrum, and patterns
of linkage disequilibrium). In order to characterize these aspects of variation, a full
re-sequencing approach is necessary. Full re-sequencing data are also necessary to
uncover the variant that underlies a disease association signal and to narrow down
the location of an advantageous variant. Next-generation sequencing technologies
offer new opportunities for population genetics beyond the conventional and low
throughput capillary-based sequencing.
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Finally, under a high pathogen load, genetic variants resulting in over-responsive
immunity (e.g., ADRVs) can be advantageous. This raises the possibility that some
of the ADRVs were evolutionarily advantageous at some point during human his-
tory. In addition, if pathogen loads vary across populations, the frequency of over-
responsive immune variants may differ substantially as a result of local adaptations.
Indeed, a preliminary analysis of ADRVs identified in genome wide association stud-
ies (GWAS) showed that several of these variants carry signals of positive natural
selection. In addition, consistent with the idea that these variants were the targets
of local adaptations, their geographic distribution is often restricted to closely re-
lated populations. For example, some ARDVs seem to have been locally selected
in Europeans, perhaps during the Neolithic period. Moreover, autoimmune disease
prevalence differs among ethnic groups even when they live in similar environments,
e.g. ethnically diverse populations living in the United States.
In conclusion, reconstructing the chronology of local adaptations will yield important
insights into the origin of ADs. Answering where and when selective factors shaped
genetic variation has the potential to understand the evolutionary history of the
autoimmunity phenotype, which in turn will be used to guide the future search to
define the key populations and the causative ADRVs to be functionally studied.
4.1 Methods
4.1.1 Selection of the AD-risk regions.
Two general AD loci with signatures of European local adaptation were selected:
4q27 and 12q24. Interestingly, the protective/derived allele in 4q27 and the risk/derived
allele in 12q24 are associated with signals of positive selection in Europe (i.e., re-




It represents a general AD risk locus. WTCCC found a risk haplotype highly as-
sociated with T1D [161], which was later replicated with rs17388568 for T1D and
associated with Grave’s disease (GD) [162]. To be noted, the intergenic rs6822844*C
(ancestral) allele was a perfect proxy for the risk haplotype highly associated with
T1D [163, 164], RA [163–167], CD [164, 168, 169], ulcerative colitis (UC) [168, 169]
, juvenile idiopathic arthritis (JIA) [170], psoriatic arthritis (PSA) [171], psoriasis
(PS) [171], early onset psoriasis [172] and SLE [163]. In addition, in a CeD GWAS,
besides the HLA region, rs13119723 was the most significant finding, but a follow-up
in two cohorts highlighted rs6822844*C with even stronger risk-association p-value
(meta-analysis p-value = 1.3 × 10−14) [173, 174] and replicated in a Scandinavian
CeD cohort [175].
All those polymorphisms were present in a strong LD block containing four genes:
KIAA110, ATP-dependent DNA helicase (ADAD), interleukin (IL)-2, and IL-21.
IL-2 and IL-21 are strong AD candidate genes. For example, IL-2 is an important
cytokine in T and B lymphocyte proliferation; about half of IL-2 deficient mice
die of autoimmune haemolytic anaemia before 2 months of age, and the survivors
develop inflammatory bowel disease [176, 177], which suggests an essential role of
IL-2 in the immune response to antigenic stimuli. In addition, the receptor of the
type I cytokine IL-21 is expressed on T, B, and NK cells; and BXSB-Yaa mice,
which develop a SLE-like disease, have greatly elevated IL-21, suggesting a role for
IL-21 in the development of AD [178]. Overall, the ancestral/risk alleles/haplotype
of T1D, GD, RA, CD, UC, JIA, PSA, PS, early onset PS, SLE and CeD appear
to be the same, and of similar frequency, which are significantly correlated with
climate variables, and latitude. Interestingly, the derived/protective rs6822844*T
allele shows evidence of recent selection in the HapMap CEU - European population
(iHSCEU = −1.958). Furthermore, this protective/derived/selected allele is only
present in Europe, Middle East, West Asia, and the Siberian Yakut population,
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while the risk allele is fixed in the remaining HGDP populations (Figure 4.1).
Figure 4.1: Pie chart of the allele frequencies worldwide for the SNP
rs6822844. Pies report the allele frequency distribution in each one of
the 53 HGDP population (derived allele is in orange). From the HGDP
Selection Browser.
Chromosome 12q24 region
The chromosome 12q24 also represents a general AD risk locus. 12q24 harbors a
large number of SNPs significantly associated with T1D [161]. The ancestral/risk
allele of rs17696736 - GW significant p-value - showed evidence of recent selection
in the European population (iHSCEU = −3.21) and its frequency is correlated with
latitude. Interestingly, in the follow-up replication study [162], four SNPs for which
the LD r2 values with rs17696736 ranged from 0.59 to 0.82 were tested and the nsSNP
in exon 3 of SH2B3 encoding a pleckstrin homology domain (R262W- rs3184504)
had the highest association (p-value = 1.73 × 10−21; odds ratio (OR) = 1.33, 95%
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c.i. = 1.26 − 1.42). This single nsSNP was sufficient to model the association
of the entire region [162]. Not only the derived rs3184504*T allele increased risk
for T1D [161], but also for CeD [173], multiple sclerosis (MS) [179], myocardial
infarction [173] and is correlated with the Soluble ICAM-1 (sICAM-1 ) which is and
endothelium-derived inflammatory marker that has been associated with diverse
conditions such as myocardial infarction, diabetes, stroke, and malaria [180].The
derived/risk rs3184504*T allele is also present in the longer haplotype suggesting
that it was recently advantageous.
Interestingly, (1) multiple SNPs in this region have |iHSCEU | > 2, suggesting strong
recent selection on variation in this region in the European population; (2) this region
is significantly enriched for high FST (CEU vs. ASN and CEU vs. YRI) values; and
(3) the the worldwide distribution of rs3184504 is similar to other AD-risk alleles
in this candidate region: Europe, Middle East, West Asia, and the Siberian Yakut
population (Figure 4.2). SH2B3 is strongly expressed in monocytes and dendritic
cells, as well as to a lesser extent in resting B, T and natural killer (NK) cells
(Genomic Novartis Foundation SymAtlas [181]). The observed higher small intestine
SH2B3 expression in inflamed celiac biopsies may reflect leukocyte recruitment and
activation [173].
SH2B3 regulates T-cell receptor, growth factor and cytokine receptor-mediated sig-
naling implicated in leukocyte and myeloid cell homeostasis [182]. The R262W
amino acid change in the pleckstrin homology domain may be important in plasma
membrane targeting [173]. SH2B3−/− mice have increased responses to multiple
cytokines [183].
OCA2
In addition to the previous regions, we selected a third genomic region in chromo-
some 15 which is not associated with AD but blue eye-color in Europeans. It is
another variant that even if it is associated with a completely different phenotype,
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Figure 4.2: Pie chart of the allele frequencies worldwide for the SNP
rs3184504. Pies report the allele frequency distribution in each one of




shares similar features with the above mentioned AD loci. Variation in rs12913832
is relatively common in Caucasians though rare among other ethnic groups [184] and
correlates with skin, eye, and hair color variation [185] (Figure 4.3). For example, the
G/G genotype is associated with blue eye color [184, 186]. As a note, rs12913832 is
part of the “h-1” haplotype, spanning 166kB and found in homozygous state in 97%
of individuals with blue eye color [184]: rs4778241(C), rs1129038(A), rs12593929(A),
rs12913832(G), rs7183877(C), rs3935591(G), rs7170852(A), rs2238289(T), rs3940272(C),
rs8028689(T), rs2240203(A), rs11631797(G), and rs916977(G). rs12913832 is near
the OCA2 gene and may be functionally linked to eye color due to a lowering of
promoter activity of the OCA2 gene.
Figure 4.3: Pie chart of the allele frequencies worldwide for the SNP
rs12913832. Pies report the allele frequency distribution in each one of
the 53 HGDP population (derived allele is in orange). From the HGDP
Selection Browser.
We included this region for two reason. First of all, it is known that this gene
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underwent selective pressure after the out of Africa migration. For this reason, this
region will represent a sort of benchmark for the age estimation method. On the
other hand, skin pigmentation has a direct effect on vitamin D metabolism that, in
turn, play a central role on the immune system. Hence, it could be important to
understand the timing of the selection process of this gene with respect to those of
the previous regions.
4.1.2 Selection of samples
DNA of 14 European individual genomes from the Centre dO˜Etude du Polymor-
phism Humain (CEPH) was purchased from the Coriell Cell Repository (http:
//ccr.coriell.org) with the corresponding genotypes for the targeted-SNPs
(i.e., chr4:rs6822844; chr12:rs3184504 and chr15:rs12913832). As a note, allele T in
chr4 and chr12, and allele G in chr15 show evidence of recent selection. Individuals
were selected in order to enrich the sample for the selected alleles. This led to the
following composition:
rs6822844 3× T/T homozygotes and 11× G/T heterozygotes
rs3184504 5× T/T homozygotes and 9× C/T heterozygotes
rs12913832 11× G/G homozygotes and 3× A/G heterozygotes
4.1.3 Design of the capturing arrays and sequencing
First, to define the coordinates of the region to be captured/sequenced, per each re-
gion, the targeted-SNPs (i.e., chr4:rs6822844; chr12:rs3184504 and chr15:rs12913832)
were used as the reference. Per targeted-SNPs, all SNPs with r2CEU > 0.2 and within
2 Mb were selected. The SNP with the lower and the SNP with the higher coordi-
nate defined the region to be captured. This resulted in a 2.26Mb region for chr4;
1.9 Mb for chr12; and 1.47 Mb for chr15. However, the SNPs whose coordinates
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limited the length of the chr4 and chr15 region resulted to be outliers among the rest
of the LD-SNPs. Once removed, the coordinates of the regions to be captured and
sequenced were defined as follows (hg 18): chr4: 122729299-123782528 (1.053 Mb);
chr12: 109769404-111681303 (1.911 Mb), and chr15: 25542017-26213429 (0.671 Mb).
Second, NimbleGen designed the capturing arrays (OID20617) by first masking the
repeats of the requested regions and designed unique probes (with an average of
∼ 85bp) as determined by the SSAHA algorithm. These unique probes allowed
for up to 5 insertions, deletions or mismatches. Only unique probes were designed.
Finally, 72.3% of the targeted regions were directly covered by probes, and 86.5%
of the regions were either directly covered or within 100bp of a probe.
Capturing was performed on Roche 385K NimbleGen Capturing Arrays. The cap-
turing protocol was modified so that Illumina next-generation sequencing method
could be used instead of 454 sequencing.
Two different sequencing runs were performed in the Illumina Genome Analyzer II
using paired-end 76 bp reads. The number of reads obtained per sample is summa-
rized in Table 4.1.
4.1.4 Raw data preprocessing
Sequencing data alignment
First, the human reference genome version b36 was obtained from GenomeAnal-
ysisToolKit (GATK) website as part of the GATK resource bundle. Second, the
obtained reads were aligned to the reference genome using BWA 0.5.9rc1 [187].
The search for suffix alignment coordinates (bwa aln) and the alignment (bwa
sampe) were both performed with the default parameters (see http://bio-bwa.
sourceforge.net/bwa.shtml); but within the alignment step (bwa sampe),
we changed the following parameter values from the default: (i) -a (maximum in-
sert size for a read pair to be considered being mapped properly) 600 was used
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instead of the default value of 500; and (ii) -r @RG\tID:<unique id>\tSM:<sample
id>\tPU:<lane>\tPL:ILLUMINA was used instead of the default ’none’ to specify
the read group for each sample. The latter was needed by GATK since samples were
going to be pooled before the SNP calling step. Third, following GATK’s “Best prac-
tice for variant detection v. 2”, realignment around indels was performed. We per-
formed sample-level realignment with known and novel indels using GATK 1.0.4905
and default parameters. Known indels were from obtained from dbSNP 130. Novel
potential indels were obtained with GATK RealignerTargetCreator. The number of
aligned reads per sample is summarized in Table 4.1.
Using Picard-tools 1.38 and default parameters (http://picard.sourceforge.
net/), a different BAM file is created per sample with unique, sorted and indexed
reads. Also the duplicated reads (i.e. read pairs with the same orientation and
alignment position) were removed using Picard-tools.
Base quality score recalibration
The base quality scores were recalibrated to get them closer to the actual proba-
bility of a read mismatching the reference genome using GATK 1.0.4905 with de-
fault parameters and QualityScoreCovariate, CycleCovariate and DinucCovariate
as covariates (http://www.broadinstitute.org/gsa/wiki/index.php/
Base_quality_score_recalibration). ReadGroupCovariate was not used
because for each sample all reads belong to the same group. GATK walks over all
of the reads and tabulates data about the selected covariates: assigned quality score
× machine cycle producing this base × current base + previous base (dinucleotide).
For each of such bin, it counts the number of bases within the bin and how often such
bases mismatch the reference base, excluding loci known to vary in the population
(according to dbSNP). The new quality score is the sum of the global difference be-
tween reported quality scores and the empirical quality, plus the quality bin specific
shift, plus the quality-per-cycle and quality-per-dinucleotide effect.
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Indels and genotyping call
Indels were called, per sample, using GATK and default parameters according to
GATK’s “Best practice for variant detection v. 2”.
Genotypes were called using the default parameters and the “pooled” method. Only
variants in the targeted regions or 400bp up- or down-stream of a targeted region
were called.
A set of filters was then used to discard low quality genotype calls. The “called/ac-
cepted” variants satisfied the following conditions: (1) QUAL > 50 (PHRED-scaled
quality of the variant); (2) QD > 5 - Quality by Depth; (3) SB > −0.10 -
Strand bias (variant allele is supported by reads that map to both strands?); (4)
HRun > 5 - largest contiguous homopolymer run of variant allele in either direc-
tion; (5) MQ0 > 4 or MQ0 > 0.1 ×DP - number of covering reads with mapping
quality score zero; (6) Not in cluster, defined as 3 SNPs in 10bp and (7) not inside
an indel.
Comparing our data with the HapMap genotype calls, our mean concordance is
99.97%; our false positive (i.e. HapMap homozygote called heterozygote) was 0.01%;
our false negative rate (i.e. HapMap heterozygote called homozygote) was 0.02%;
our non-reference sensitivity (i.e. fraction of variant sites in HapMap that we call
variant) was 96.91%; and finally, our non-reference discrepancy rate (i.e. discrepancy
of genotype call excluding concordant reference homozygotes calls) was 0.08%.
Haplotypic phase determination
IMPUTE2 was used for imputation and phasing using the whole HapMap panel as
reference panel. The default values were used, except (1) the number of iterations
was increased from 30 to 50; and (2) the maximum number of copying states to
use for diploid phasing updates was also incremented from 80 to 100. To increase
phasing performances, also variants sampled in the HapMap panel and falling in
78
4.1 Methods
non-targeted regions were considered. Those variants were then discarded. Also, we
discarded all variants were at least one of the genotype was imputed.
Identification of the subregions
For the age estimation purpose, we simulated only a smaller part of the regions. This
allowed us to decrease the computational cost of the method and also to improve
the estimation. Indeed, in this way summary statistics are mainly affected by the
haplotype, without dilution of the information due to larger, neutral regions. To
select the subregions, we took into account two aspects, namely the position of
the haplotype and the presence of strong recombination hotspots. First, selected
haplotypes were roughly identified by visual inspection for each region. Then, the
“selected subregion” was obtained as the subregion including the haplotype and
enclosed between either the edge of the targeted regions and/or a strong (> 20×
the background recombination rate) recombination hotspot.
For Chr4, haplotype spans about 500 kbp and selected subregion goes from (hg 18)
123,100,000 to 123,800,000 for a total of 700 kbp; for Chr12, haplotype spans about
700 kbp and selected subregion goes from 109,900,000 to 111,500,000 for a total of
1.6 Mbp; for Chr15, haplotype spans about 300 kbp and selected subregion goes
from 25,850,000 to 26,100,000 for a total of 350 kbp (Figure 4.4).
4.1.5 Allele age estimation
One of the most interesting question in population genetics, today, is to understand
“why” (the functional relevance) and “when” (the timing) loci underwent positive
selection. The two questions are, of course, strictly related and answering to one
can help in the understanding of the other one.
Regarding the timing, what researchers are primarily interested into is the age of
the onset of the selective pressure. This quantity, indeed, can potentially provide
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Figure 4.4: Genetic map of the captured regions. On the y-axis is reported
the recombination rate in cM/Mb. Yellow boxes represent the “selected
subregions” while vertical red dashed lines mark the haplotypes. With
a blue triangle is marked the position of the selected SNP.
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important hints on why the allele was selected and, eventually, its biological role.
Unfortunately, this quantity is hard to estimate also because of its vague definition.
For this reason, two proxies commonly used are the time since the most recent com-
mon ancestor (tMRCA) and the age of the allele (that is the time of the mutation,
assuming that the selection occurred on a new allele). Relative relationship among
these quantities are shown in Figure 4.5.
Figure 4.5: Cartoon of selection acting on a new mutation. Coalescent tree
showing the relative relationship among onset of selection, age of the
mutation (red cross) and time since most recent common ancestor (black
circle).
Several analytical methods have been proposed to estimate the age of specific classes
of alleles, namely rare, near to fixation or fixed [188–190]. However, it is possible to
show that given the estimated human effective population size and realistic selection
coefficients, sweeps occurred after the out of Africa are, on average, incomplete [191]
and thus selected alleles are likely to be at intermediate frequencies.
Among the most used allele age estimation methods, particular attention deserves
the haplotype decay method. A relatively simple and widely used implementation
of this method was proposed by Voight and colleagues [25]. The main idea comes
from the fact that the probability of observing two identical chromosomes at a given
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recombination distance, decay exponentially with the time. In particular, given r
the recombination distance at which the two chromosomes are still identical and T
the tMRCA expressed in number of generations,
P (Homo) = e−rT .
This method makes some simplifying assumptions about the demographic model
which make it unsuitable in many real application. In particular, they assume a
population that is panmitic and constant in size, which is clearly unrealistic for
human.
Another interesting approach, known as counting method, comes from Thomson
and colleagues [190]. This method starts building a tree for the region of interest
and counting the number of mutations. Since neutral mutations accumulate at a
constant rate, the total number results to be proportional to the tMRCA. Given xi
the number of mutations on branch i (from the root to the tip, and thus the number







Contrarily from the haplotype decay, this method makes no assumptions on the
demographic model. However, it only consider one tree per region and thus its
interpretation in presence of recombination is not straightforward.
Moreover, both these methods as well as many others, usually just provide a punc-
tual estimation of the age and no general rules exist to assess the confidence interval
of these estimations.
Many methods for parameter estimation that are also able to provide confidence/-
credible intervals are based on the concept of likelihood, that it the probability of
the data given the parameter. Given an unknown (set of) parameter θ and the data
D, for the Bayes’ rule
P (θ|D) ∝ P (D|θ)Pθ = L (θ)Pθ (4.1)
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where L (θ) is the likelihood of θ and Pθ is the a priori distribution of θ.
Usually, the likelihood function is derived from theory. In the case of age estimation,
this can include population genetics and coalescent theory. The problem with this
approach, however, is the difficulty of deriving such a likelihood function, and this
restrict their applicability to very simple scenarios.
A different class of methods tries to overcome this problem bypassing the exact
likelihood calculation by means of simulations and a set of quantities (hereafter called
“summary statistics” or SSs) that summarize the data. One of these approaches is
known as Approximate Bayesian Computation (ABC) [192]. The main intuition is
very simple. Suppose you can calculate from the data a minimal set of quantities
able to represent all the information contained in it and let’s call S(D) this set of
summary statistics calculated on the data set D. Moreover, suppose an appropriate
model M for the data is available. In other words, suppose it is possible to generate
simulated data sets where the underlying model is the same as the real data. The
na¨ıve implementation, using a simple rejection schema, is as follows:
1. sample a θ∗ value from Pθ,
2. generate a new simulation X∗ under the model M with parameter θ∗,
3. if S(X∗) = S(D) then accept θ∗.
The idea behind ABC is that it is possible to approximate the a posteriori distribu-
tion of the parameter θ using the a posteriori distribution of the accepted parameter
θ∗. That is
P (θ|D) ≈ P (θ∗|X∗) (4.2)
In the practice, the probability that a simulation X yields to a S(X) that is exactly
equal to S(D) is almost vanishing. For this reason, instead of considering simulations
that are “exactly” as expected, one can consider all simulations that are “similar”
or “close enough” to the expected value. Formally, given a distance metric ∆(·, ·)
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(e.g. Euclidean distance), it is possible to reformulate the third step as: 3. if
∆ (S(X∗, S(D)) ≤  then accept θ∗, where  is an arbitrary similitude threshold.
A statistic S is “sufficient” if P (D|S(D), θ) does not depend on θ. In other words,
if S provides as much information to estimate θ as the whole data set. It is possible
to show that if S is sufficient, for vanishing  the relationship in Eq. 4.2 tends to an
equality.
A clear advantage of the ABC approach is that it can deal with models on any
complexity, given the fact that simulations of the data under the model still remain
feasible. On the other hand, one of the limitations is given by threshold . Indeed,
it is worth to stress that  has a double role: on one hand one wants to keep this
value as low as possible to increase the precision of the approximation, but this
also decrease the acceptance rate yielding a prohibitive computational cost. On the
other hand, increasing the value will increase the acceptance rate as well but can also
distort the approximation because all the retained simulations are treated equally,
independently from the actual distance ∆ (S(X∗, S(D)).
One of the first strategies to overcome this limitation was proposed by Beaumont
in 2002 [192]. Without going into details, I just want to recall the main idea that is
to improve the approximation by weighting the θ∗ according to the actual distance
∆ (S(X∗, S(D)) and adjusting their values using local-linear regression to weaken
the effect of the discrepancy between S(D) and S(X∗).
4.1.6 Algorithm and implementation
The method for age estimation of selected allele under positive selection via ABC
can be summarized as follows:
1. generate a new simulations X∗ where the mutation of the allele under positive
selection occurred t∗ generations ago;
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2. emulate all the characteristics of the re-sequencing data;
3. calculate S(X∗);
4. if ∆ (S(X∗, S(D)) ≤  then accept t∗;
5. finally, calculate the a posteriori P (t|D) using Eq. 4.2
I’m now going to discuss more in details each one of the previous steps. It is worth to
notice that in the implementation of the method I’m going to estimate the logarithm
of the age of the allele (t) instead of t. This is because we are more interested in
differences in orders of magnitude of the age than on the exact value. Moreover,
many SSs have an almost linear linear relationship with log(t), and this allows to
improve the estimation since there are steps where a linear relation is assumed (e.g.
local-linear regression).
Step 1 – Generation of simulations
The first, crucial step for using ABC is the capability of producing simulations with
the same underlying model as the real data. To this aim, we used mssel, a modified
version of ms [193] kindly provided by Richard Hudson. This simulator uses a
coalescent approach to generate neutrally-evolving regions linked to a site at which
an allele is under selection, allowing recombination, gene-conversion and a variety of
demographic model. Some parameters are required in order to resemble the specific
region.
First of all, one needs to specify the sample composition desired in the output in
terms of the number of haplotypes carrying the ancestral and the derived allele at
the selected site. We used, for each region, the same composition as in the real data.
As stated before, samples were enriched for the derived allele, hence in this way we
kept the same bias also in the simulations, allowing us to directly compare real and
simulated summary statistics.
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The second set of parameters are the population mutation (Θ) and recombination
(ρ) rates. For both of them, we assumed Ne = 12000. ρ was estimated, for each
region, from the HapMap data. The mutation rate, instead, was calculated based
on the divergence from other species and using 1000 Genomes Project data (www.
1000genomes.org). The ancestral sequence for each base were defined by the 4-
way (human, chimp, orangutan, rhesus) EPO alignments (ftp://ftp.ensembl.org/pub/release-
54/emf/ensembl-compara/epo 4 catarrhini/). Only sites where the mutation oc-
curred in the human lineage (uppercase in the 1000 Genomes Project notation:
chimp, orangutan and rhesus sequence agree, human disagree) were considered. We
then counted the number of derived alleles fixed in the whole 1000 Genomes Project
sample (June 2011 release) and thus estimated the mutation rate assuming 5My
split time and 25 years per generation. We obtained a consistent estimation of
1.2 mutation/generation/bp for all of the three regions. Interestingly, the region
in chromosome 12 showed a decrease of nucleotide diversity in all the population
(also in YRI, where there should be no selection). Using pi estimator, we obtained
a mutation rate of 0.6 for this region, roughly consistent in CEU, YRI and ASN.
Demographic model was obtained from [194]. Briefly, a 10-fold reduction of the
population (bottleneck from 12,000 to 1,200) occurred between 27,500 and 40,000
years ago. A 10-fold expansion (from 12,000 to 120,000) then started 12,500 years
ago.
Last input provided is the trajectory for the selected allele. While the previous
parameters are kept, a new trajectory is generated for each simulation, varying the
time when the mutation occurred but such that all of them ends with the actual
frequency of the allele in the real population (CEU population, HapMap data).
This device will ensure that all simulations will match the real data for the final
frequency of the allele. First, a generation t∗ is randomly drawn from a log-uniform
(distribution uniform in the log space) a priori distribution between log(50) and
log(3000). As stated before, indeed, we are going to estimate log(t) instead of t
and the use of a flat a priori will not affect the estimation (maximum uncertainty).
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After that, a selection coefficient s is drawn from a uniform distribution between 0
and 0.1. Given the starting point t∗, a trajectory is simulated forward time using
s and a co-dominant diffusion process. If the final frequency of the allele matches
the desired one (accounting for a sampling error), then the trajectory is saved and
a coalescent simulation is generated. Otherwise, a new value for s is drawn and the
process is repeated. Notice that in this process any time t has equal probability
despite of different population size across time. We explicitly take into account this
aspect in the step 5.
Step 2 – Introducing potential sources of error
Re-sequencing data are affected by some biases that could, in principle, influence
the estimation. The strategy adopted was to try to identify these potential sources
of errors and try to include them in the simulations as far as possible. In this way,
even though these factors have an effect, they are took into account and simulations
and real data are still comparable.
Among the features that more likely could have an effect, the most relevant are (i)
the small sample size (14 individuals), (ii) the presence of region un-targeted and,
most likely, un-sequenced sub-regions (gaps), (iii) phasing uncertainty for novel and
rare variants and (iv) the complex demographic history of sequenced individuals
(Europeans). In the following I’m going to present how each feature is introduced in
the simulations and the comparison, in terms of relative error, with a vanilla model
in which the feature is absent.
Even if the cost per base is decreasing every day, re-sequencing is still an expensive
technology. For this reason, the number of individuals that can be analyzed is
strongly limited by the available budget. Hence, the first analysis was aimed to
assess the effect of a small sample size. In Figure 4.6 is reported the relative error
of the ABC point estimates (posterior median) for different sample sizes (number of





, where, for each simulations, t is the age of
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the allele in that particular realization and tˆ represent its ABC estimation. A value
of 1.0 or −1.0 corresponds to a two-fold over- or under-estimation, respectively. Is
it possible to see that, even though a bigger sample size actually decreases both
the bias and the variance of the estimation, the improvement is not justified by the
increasing sequencing cost.
Figure 4.6: Boxplot of log2 ratio of the estimate to the true age of the
allele using different sample sizes. 10, 000 simulations are produced
as described in step 1, but with a constant population size (N = 10, 000),
uniform recombination rate, additive dominance and with the selected
allele at a frequency of 50% in the population and in the sample.
As discussed in Section 4.1.3, the probes on the capturing array were designed
masking repetitive elements. This means that subregions for which no probes were
inserted on the chip are likely to remain un-sequenced. Actually, this is not totally
true because a single fragment of DNA (and thus the two reads associated) can
straddle a targeted and an un-targeted subregion. Hence, considering the typical
length of the DNA fragments and the length of the reads, it is plausible that variants
lying in the un-targeted subregions but within 200bp from a the edge (i.e. a targeted
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subregion) still have enough coverage to be confidently called. On the other hand,
variants to far from a targeted subregion will be missed and this can result in an
overall decrease in the number of segregating sites in the regions. We emulated this
potential bias in the simulations with a very simple approach. We removed from
the simulated haplotypes all the segregating sites distant more than 200bp from a
targeted subregions, according to their positions in the real regions2. Again, the
presence of gaps influences in a negligible way the quality of the estimation (Figure
4.7).
Figure 4.7: Boxplot of log2 ratio of the estimate to the true age of the
allele in simulations with (blue) and without (yellow) gaps.
Simulations parameters are the same as those reported in the caption of
Figure 4.6
Next generation sequencing is one of the best way to identify novel and rare variants.
Although they are crucial for population genetics in general and for the aim of this
work in particular (2 out of the 3 summary statistics used relies on them), those
2NimbleGen provided a BED file with the positions, for each of the three regions, of the regions
for which probes were designed
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variants are, unfortunately, hard to correctly phase since no other examples are
presents either in reference panels (novelty) or in the sequenced population (rarity).
Of course, this problem is less severe with the increase of the allele count (interme-
diate or high frequency variants). On the other hand, all variants outputted by the
simulator are, by construction, correctly phased. We introduced this uncertainty in
the phasing in the simulations as well, but under some simplistic assumptions: (i)
all variants with a count greater than 2 are correctly phased and (ii) all variants
with a count equal or less than 2 (singletons and doubletons) have a 50% chance
of being placed on the wrong chromosome. It is worth noticing that the latter is
a very conservative assumption since it is assumed that singletons and doubletons
are placed completely randomly on the chromosomes. The implementation of these
two constraints is straightforward. As a first step, we coupled chromosomes in or-
der to emulate individuals, respecting the actual composition of homozygotes and
heterozygotes of the selected SNP. Then, for each variant with a count equal or
less than 2 we randomly place, with a probability of 50%, the allele on the other
chromosome of the individual. Once again, the effect of this uncertainty is almost
absent (Figure 4.8).
Finally, we compared the performances of the estimation in simulations with con-
stant population size versus a complex demographic history (as reported in step 1).
Results are reported in Figure 4.9 divided per demographic phase (pre-bottleneck,
bottleneck, recovery, expansion). It can be seen that demography has an impact on
the estimation in the sense that both bias and variance changes over time.
Step 3 – Summary statistics
Another very important aspect of ABC is the choice of the right set of SSs. As
discussed, we wish this set to be sufficient in order to obtain an accurate estimation
of the a posteriori distribution. Moreover, because of the local-linear regression
step and of the used distance metric ∆, this set needs to be non-redundant. Several
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Figure 4.8: Boxplot of log2 ratio of the estimate to the true age of the
allele in simulations with (red) and without (yellow) phasing
uncertainty. Simulations parameters are the same as those reported in
the caption of Figure 4.6
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Figure 4.9: Boxplot of log2 ratio of the estimate to the true age of the al-
lele in simulations with constant population size (yellow) and
with complex demography (green). Four panels represents the four
demographic phases: (from right to left) before the bottleneck, during
the bottleneck, after the recovery and during the expansion. On the top
is reported a cartoon of the demographic model (green: complex demog-
raphy, yellow: constant population size) for convenience (left: present,
right: past). Simulations parameters, but demograpy, are the same as
those reported in the caption of Figure 4.6
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strategies have been proposed to face this problem [195, 196], including PCA reduc-
tion and feature selection techniques, but up to now there are no general rules and
the optimal choice still depends on the specific problem.
For the aims of our problem, we used two different sets of SSs. A first set (SC) is
used to be sure that simulated regions are actually representative of the real data
and thus that the model is an appropriate one. This set is composed by 4 SSs,
namely the number of segregating sites in the region (σ), nucleotide diversity of the
region (pi), Tajima’s D (DT ) and Fay and Wu’s H (H). These summary statistics are
calculated considering all the 28 haplotypes (i.e. derived and ancestral haplotypes
together). It is worth stressing that this set is not directly used for the estimation
of the age, but it only has check purposes. For this reasons, eventual correlations
among these 4 SSs are non influential. For each region, we checked that SC(D) was
in the bulk of the distribution of simulated values.
The second set (S) was used for the age estimation. We choose three uncorrelated
quantities known to be informative about the age of the selected allele. In particular,
we considered (i) the length in genetic distance of the non-recombining haplotype
surrounding the selected allele (LH), (ii) the number of mutations accumulated in
this haplotype (MH) and (iii) the number of singleton variants divided by the total
number of segregating sites in the haplotype (RH). This set of SSs is calculated only
on the set of chromosomes carrying the derived (selected) allele.
The haplotype was defined using the same approach proposed by Voight and col-
league to define the region to integrate in the calculation of their iHS statistic [25].
Namely,the boundaries are defined as the positions away from the selected allele
(core) where the extended haplotype homozygosity reaches 0.05. The first SS is the
length of this haplotype. However, since the actual genetic map for the real data is
non-uniform (as assumed in mssel), LH is normalized, separately in the simulated
and in the real data, by the total recombination length of the region. Interestingly,
this SS is strictly related to the Voight’s implementation of the haplotype decay
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LH MH RH age
LH 1 0.09 0.156 0.90
MH - 1 0.155 0.44
RH - - 1 0.56
Table 4.2: Correlation among summary statistics. Spearman’s correlation co-
efficients, corrected for age.
method.
The second statistic, MH , is instead related to the counting method described above.
Together, these first two SSs are aimed to capture and put together the advantages
of these two well established methods.
The last statistics, RH , comes from the observation that allele frequency spectrum,
and in particular the number of singleton variants, can be influenced by both de-
mography and selection. Because all our simulations assume the same demographic
scenario (and, hopefully, the real data too), the main influence on this number is
more likely to be due to selection. But, since the mode of selection, again, is the
same in all the simulations except for the age/strength of the selection, this number
eventually result to be informative on the age.
In order to quantify the influence on the estimation and to exclude collinearity,
we calculated the correlation among these three SSs as well as the correlation be-
tween each of them and the age (Table 4.2). Correlations among SSs is calculated
correcting for age in order to exclude spurious correlations.
Step 4 – Acceptance criterion
We chose Euclidean distance as ∆(·, ·) function, so that acceptance regions are
spheres [192]. Regarding the value of , we again followed the approach originally
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proposed by Beaumont and we set  to be a quantile, P, of the empirical distribution
function ∆ (S(X∗, S(D)). In the specific, we used P = 0.001 meaning that the 0.1%
of simulated X∗ that are closest to D are retained.
Step 5 – A posteriori density estimation
Once obtained the set of {X∗} as defined in the previous step, the a posteriori
density is estimated using a Gaussian kernel with a bandwidth chose following Sil-
verman’s “rule of thumb” (R default option). As pointed out in step 1, the size of
the population at the particular t∗ is not considered. But, since the probability for
a mutation to occur is proportional to N ,the density estimation process explicitly
take into account this fact by weighting each t∗ by N (t∗).
4.2 Results and Discussion
In the previous section I described how data for the three regions were obtained
and how ABC works. As stated, one of the step is to check that the model used to
generate simulations is a good model for the data. In general, this is an hard problem
and no definitive solutions exist yet. To assess, at least qualitatively, this point we
checked whether the the simulator was able to produce haplotypes “compatible”
with the real ones. In particular, we verified that the all the summary statistics in
the “control set” (SC , see 4.1.6) were in the bulk of the respective distributions of
simulated values. Results are reported in Figure 4.10, 4.11 and 4.12.
It is possible to see that the simulations of regions on chromosome 4 and 15 do fit
the real data. Unfortunately, this is not true for the region on chromosome 12. As
it can be seen, the region exhibits a lower nucleotide diversity than what the simu-
lator is able to reproduce. It is worth remarking that these four SSs are calculated
considering both the derived and the ancestral (which are supposed to be neutral)
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Figure 4.10: Comparison between real and simulated “control” summary
statistics (SC) for region on chromosome 4. Distribution of the
four summary statistics in the control set (SC) for the simulated region.
Red line indicates the true value of the SS for the real region.
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Figure 4.11: Comparison between real and simulated “control” summary
statistics (SC) for region on chromosome 12. Distribution of the
four summary statistics in the control set (SC) for the simulated region.
Red line indicates the true value of the SS for the real region.
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Figure 4.12: Comparison between real and simulated “control” summary
statistics (SC) for region on chromosome 15. Distribution of the
four summary statistics in the control set (SC) for the simulated region.
Red line indicates the true value of the SS for the real region.
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haplotypes and, given the nature of the statistics and the composition of the sam-
ple, they should be dominated by these latter. If we look at the same statistics, but
calculated only considering the derived haplotypes, the situation is different (Figure
4.13). This time, simulations seem to fit the real data. Putting together, these re-
sults suggest the presence of some uncontrolled phenomenon affecting the “neutral”
background (background selection, higher gene content, the presence of a previous
sweep). However, the statistics calculated only considering derived haplotypes sug-
gest that the model is good enough to represent, at least, the selection phenomenon.
For this reason, and given the fact the the set of SSs used for the estimation only
consider derived haplotypes, we are confident in proceeding with the age estimation
also for the allele in this region, even though further investigations are needed.
We estimated the a posteriori distribution of the age for the three alleles using
1, 000, 000 simulations for each region (Figure 4.14).
According to this estimation, the allelic variant associated with blue eyes and skin
pigmentation (on chromosome 15) arose, as expected, most probably after the out-
of-Africa when people moved to higher latitude. In particular, even tough the 95%
credible interval is wide ([7,700 − 60,000]), the most reasonable range of dates for
this allele is between the out-of-Africa migration (∼ 30,000 years ago) and the end
of the last glaciation/beginning of the agricultural era (∼ 10 − 20,000 years ago).
As mentioned, we included this variant essentially for checking purposes since it is
known that it arose after the migration out of Africa, and our estimation reflects
the expectation.
More interesting are the estimations for the two variants associated with AD. The
first thing that leaps out is that the two mutations occurred in two different mo-
ments. Credible intervals for variant on chromosome 4 and 12 are [23,000− 75,000]
and [3,300 − 18,000], respectively. Hence, the variant on chromosome 4 arose in
a period of time compatible with the out-of-Africa migration, while the variant on
chromosome 12 is likely to have been selected with the introduction of agriculture.
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Figure 4.13: Comparison between real and simulated “control” summary
statistics (SC) for region on chromosome 12, calculated consid-
ering only derived haplotypes. Distribution of the four summary
statistics in the control set (SC) for the simulated region. Red line
indicates the true value of the SS for the real region.
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Figure 4.14: A posteriori density estimation of the age of the three alleles.
Each line represents the a posteriori distribution of the age of the allele
on chromosome 4, 12 and 15, respectively.
Ideally, variants associated with ADs and under positive selection should be protec-
tive. This is the case of the variant on chromosome 4, where the derived allele shows
signature of positive selection and confers protection against ADs, too. Hence, the
most plausible explanation for the protective allele being beneficial is because of the
protection that gives by reducing ADs risk. It is worth noting that some ADs, like
T1D, have an early onset, thus they can definitively affect the fitness.
The variant on chromosome 12, on the other hand, seems to be instead compatible
with the scenario described in the introduction. With the introduction of agriculture
and animal husbandry, humans transitioned to a sedentary agricultural subsistence,
population size/density increased, and humans became attractive pathogen hosts
because large populations in small areas maximize the chance of transmission be-
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tween longer-lived barriers. Therefore, the human population growth during the
Neolithic created the conditions that favored the emergence of pathogens that spe-
cialize in human hosts. In this scenario, as described more in details in Section
4.0.4, variants conferring a higher responsiveness to pathogens can be selected, even
tough this can lead as a side effect to an over-responsiveness of the immune system
and thus an increased risk for ADs. In a recent study, Corona and colleagues found
that alleles under selection and increasing the risk of T1D are more frequent than
alleles under selection and decreasing the risk [197]. Indeed, among the 80 SNPs
most associated with T1D and showing strong signs of positive selection, 58 alleles
associated with disease susceptibility show signs of positive selection, while only 22
associated with disease protection show signs of positive selection.
Although we examined just two variants and no general conclusions can be drawn, it
seems that the balance between protection against pathogens and protection against





adaptation and the case of study of
height
Decades of work provided evidence of selective pressure in Homo Sapiens at the
level of individual genes or loci [46, 65, 198]. Among the others, methods based on
population differentiation were widely used to unveil their signature [199]. However,
in most cases, variation in phenotype among individuals is the result of a polygenic
effect, involving multiple genetic variations at multiple unlinked loci [200]. Up to
now, only few studies investigated the presence of selective pressure on polygenic
traits in humans. A possible explanation for this lack of evidence is that polygenic
adaptation might be largely undetected by conventional methods able to look for
selection [201, 202]. Furthermore, the identification of signatures of polygenic evo-
lution could require genome-scale data sources, with a well-defined set of genetic
variants involved in the polygenic effect.
Stature is one of most studied polygenic traits, because measuring height is easy
and replicable and its inheritance well recognized. Recently, genome-wide associa-
tion studies contributed in the identification of genes involved in this trait. Lango
103
Chapter 5 Future directions: polygenic adaptation
Allen and colleagues, in particular, demonstrated that hundreds of genetic variants,
in at least 180 loci, influence adult height [203]. Although this result explains ap-
proximately only 10% of the phenotypic variation in height, this study provides up
to now the most detailed description of a polygenic effect in humans at molecular
level.
From an evolutionary point of view, a complex interaction of different forces acts on
stature and the complete dynamics is still not completely clear. In particular, several
studies suggested a stabilizing selection on human height because of an increased
number of health problems in very short and very tall individuals [204, 205]. At the
same time, other studies invoked a directional sexual selection on male human height
in that taller men often have more reproductive chances [206]. Anyway, a worldwide
distributed sexual selection seems to represent an overall reasonable scenario, even
though local adaptation phenomena that could favor particular heights and body
shapes in particular environmental conditions cannot be excluded.
In this work we explored, in a simple simulated model, the behavior of FST on
a generic polygenic trait. We then investigated whether a similar behavior was
observable in a real case, namely in the set of loci related to height. 1
5.1 Results and Discussion
To analyze the behavior of FST on a polygenic trait, we started by simulating the
action of a polygenic stabilizing selection pressure in a very simple model. Such a
model relies on the following simplifying assumptions: (i) each contributing allele has
small and relatively equal additive effects, without neither environmental influences
nor non-linear effects (dominance, epistasis, etc), (ii) individual fitness is given by
1The results presented in this chapter are published in: Amato R, Miele G, Monticelli A and
Cocozza S. (2011) Signs of selective pressure on genetic variants affecting human height. PLoS
ONE 6(11): e27588
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a bell-shaped curve where the maximum is achieved by individual owning only a
part of the advantageous alleles, (iii) no migration or demographic events affect the
populations.
Under these simple assumptions, we observed that the set of alleles involved in
the phenomenon has a higher mean FST value than those subject to genetic drift
only. We thus checked whether the same behavior was observable in the 180 loci
influencing adult height. Indeed, more than 80% of its variation within a given
population is estimated to be attributable to additive genetic factors of small effects.
Moreover, the authors found no evidence that non-additive effects including gene-
gene interaction would increase the proportion of the phenotypic variance explained
[203]. In the light of this, our simulations seem to reasonable model this scenario
and, for this reason, we explicitly searched for an increase in the mean FST value of
the 180 variants associated to height.
We found in the FST distribution for these variants an overrepresentation of higher
values with respect to the genomic background (median=0.1 vs. 0.086; p=0.0356,
one-tailed Mann-Whitney test; Figure 5.1). We investigated for potential confound-
ing factors, first of all whether the increase was just due to the presence of outliers.
We thus excluded from the initial set of height related variants those falling in the
top or in the bottom 5% tail according to the genomic distribution of FST , obtain-
ing a set of 161 SNPs (hereafter denoted as “core set”). The number of outliers
excluded is compatible with the expected 5% (4% and 5% of the SNPs falling in
the top and in the bottom tail, respectively). Moreover, the “core set” still exhibits
a significant overrepresentation of high values FST value (median=0.1 vs. 0.086;
p=0.0232, one-tailed Mann-Whitney test).
In a recent paper, Pritchard and Di Rienzo argued that a signature of selection
on a polygenic trait should reasonably be small and spread across the loci [207].
Our result is, to some extension, in agreement with this hypothesis. Indeed, the
increased FST value is not dominated by few outlier loci, but small and distributed.
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Figure 5.1: FST density distribution for the genomic background and the
height associated variants. Green lines mark the 5th and 95th per-
centiles of the genomic distribution.
From this point of view, also the low value of statistical significance that we found
could be expected.
On the other hand, if we consider height either under a stabilizing selective pressure
or a worldwide distributed sexual selection, the higher mean FST value could seem
unexpected. Under these hypotheses, indeed, we expected a result that is opposite
to that obtained, even in presence of marginal phenomena of local adaptation. In
these conditions, one should expect the majority of the genes having a vanishing
FST and some outliers with very high values of FST . But looking at the simulated
alleles trajectories over time, a possible explanation could be suggested. In simula-
tions, one can observe that, in different populations, different sets of alleles become
prevalent (Figure 5.2). In particular, the dynamics favors in each population the
prevalence of a specific subset of alleles among the large amount of different subset
choices all capable to maximize the phenotype under selective pressure. In absence
of extraneous forces, the choice of the allele subset for each population is just ran-
domly driven and, hence, it is highly probable to be different for each population.
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This results in an increase of the mean diversity among the populations.
Figure 5.2: Trajectories of the allelic frequencies for markers under poly-
genic selection in three simulated populations. Each column, i.e.
top and bottom panel together, represents a different population. Top
panels show trajectories over time for the set of 10 alleles under polygenic
selection; bottom panels show trajectories for set of 10 neutral alleles.
Different colors mark different alleles, consistently across populations.
This very simple model resembles the behavior of a well-known statistical mechanics
phenomenon denoted as Spontaneous Symmetry Breaking (SSB). This mechanism
generally plays a relevant role in system self-organization, and it is common in many
fields of Natural Sciences where a system described in a theoretically symmetrical
way ends up in a non-symmetrical state. The physics of condensed matter probably
provides the most striking examples of SSB phenomena. In a ferromagnet cooled
below its critical temperature, as the thermal fluctuations slow down, will become
energetically favorable the appearance of domains where all elementary magnets
point in the same direction, randomly chosen, and hence breaking the original rota-
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tional symmetry.
SSB has been widely observed in biological systems. Population genetics also pro-
vides examples of SSB even though in this case to lead the breaking are the initial
conditions, stochastically modified by events like drift, bottlenecks, etc, and other
stochastic events like the born of new mutations. Among the others, we can quote
the role of symmetry breaking and coarsening in spatially distributed evolutionary
processes relevant for genetic diversity and species formation [208], and the relevance
of symmetry breaking in the long-term evolution of multilocus traits [209].
The symmetry-breaking scenario could represent a simple yet reasonable model of
the selection acting on height. But, even though height is basically under stabilizing
selection, local adaptive phenomena cannot be excluded. To explicitly explore the
presence of local adaptive phenomena, we analyzed how iHS, another marker of
selective pressure, is distributed in genetic variants involved in height. iHS is a score
specifically oriented to detect recent adaptive phenomena with higher geographical
resolution. We found that, in each population, the number of SNPs associated with
height having a value of iHS falling in the highest 5% of the genomic distribution
is compatible with the expectation (varying from 4-7% across populations; Figure
5.3). This finding seems to indicate that, even if recent local adaptation phenomena
cannot be excluded, their role seems to be marginal.
Another hypothesis that we explored was that loci responsible of local adaptive
phenomena on different phenotypes, in linkage disequilibrium with height related
variants, were responsible of the selective signatures that we found. Under this hy-
pothesis, the increased mean FST value that we attributed to the height associated
genes could be the by-product of selective pressures acting on other traits. To test
this hypothesis, we extracted height related SNPs that were in linkage disequilib-
rium (r2 > 0.8 in at least one population) with alleles associated to other traits
in genome-wide studies. We found 11 SNPs, 9 of which belonging to the “core
set” (Table 5.1). As far as we know, there are no clearly identified signals of selec-
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Figure 5.3: Variants associated to height with high iHS score. Red squares
indicate mark the population in which the iHS score for the variant falls
in the top 5th percentile of the respective distribution.
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tive pressure on the phenotypes in linkage disequilibrium with the height associated
SNPs. Moreover, also removing these SNPs from the analysis, the “core set” still
show a significant higher FST (median= 0.099 vs. 0.086; p= 0.03452, one-tailed
Mann-Whitney test).
We are aware that the increase in the mean FST value could be, at least in part, due
to an eventual difference across the mean heights of the three populations considered.
In other words, the increase in the mean FST value can be divided in two distinct
components, where the first one accounts for the differences in the mean height while
the second one accounts for the pure genetic differences. Unfortunately, at the best
of our knowledge, data regarding the mean height of each population are not present
in literature so far. For this reason, we were unable to estimate the relative weight
of the two components or exclude the effect of the first one. Moreover, it is worth
stressing that the 180 associated SNPs found by Lango Allen and colleagues only
explain about 10% of the variance in adult height [203]. For this reason, wherever
present, phenotypic differences among populations should have a marginal effect.
5.2 Materials and Methods
5.2.1 Data and statistical analysis
Analysis is based on the HapMap Public Release #27 (merged II+III) datafiles.
We analyzed data from the CEPH (Utah residents with ancestry from northern and
western Europe), Yoruba in Ibadan, Nigeria (YRI), Han Chinese in Beijing, China
(CHB) and Japanese in Tokyo, Japan (JPT) samples. We pooled the CHB and JPT
samples to form a single sample. Additional SNP information about physical posi-
tions and SNP-gene association were obtained from dbSNP build 129. We excluded
by this analysis SNPs that were either non sampled or non polymorphic in all the
three samples. We also excluded SNPs with a minor allele frequency < 5% in all of
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Chapter 5 Future directions: polygenic adaptation
the 3 samples. Per-population linkage disequilibrium data (r2) were obtained from
HapMap Public Release #27 (merged II+III) as well. FST was calculated using the
unbiased estimator proposed by Weir and Cockerham as discussed in 2.3. All data
was merged in a local MySQL database. As “genomic background” we refer to all
the SNPs in this database, for a total of 3, 294, 557 SNPs.
Variants associated with height were collected from [203]. Of the 180 provided SNPs,
176 were present in our database and hence considered in our analysis.
The normalized iHS scores were obtained from UCSC Genome Browser “HGDP
iHS” track. They were calculated using SNPs genotyped in 1043 individual coming
from 53 populations worldwide by the Human Genome Diversity Project in collab-
oration with the Centre d’Etude du Polymorphisme Humain (HGDP-CEPH). The
53 populations were divided into seven continental groups: Africa (Bantu popula-
tions only), Middle East, Europe, South Asia, East Asia, Oceania and the Americas.
Per-SNP iHS scores were smoothed in windows of 31 SNPs, centered on each SNP.
Data on the association of SNPs with diseases was obtained from a catalog of genome
wide association studies available at http://www.genome.gov/gwastudies,
(accessed 12/13/10).
All statistical analyses were performed with R ver. 2.10 (R Foundation for Statistical
Computing, Vienna, Austria; http://www.r-project.org/) considering 0.05
as significance threshold.
5.2.2 Simulations
We simulated three populations of diploid organisms of fixed sample size evolving
independently each other. Individuals are represented by 20 markers, where half of
them are assumed to be neutral, and the remaining ones contribute additively and
uniformly to the phenotype in a codominant way. Basically, markers evolve under
a Wright-Fisher model with recombination. Polygenic selection is then simulated
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through viability selection. Denoting with m the number of beneficial alleles carried
by an individual, each contributing with x to the phenotype, the fitness is parame-
terized as exp
(
− (m− µ)2 x2
2s
)
. In the previous expression the quantity s measures
the selection strength and µ is the number of beneficial alleles that maximizes the
fitness. In figure 5.2 it is shown a particular case where the sample size is N = 10000,
s = 10, µ = 10 and x = 5. Furthermore, the initial allele frequency is set to 0.5 for
all markers. Lower values of N increase the effect of genetic drift, while different
values of µ change the number of alleles rising in frequency in each population. By
tuning the value of x2/s one can change the strength of selection hence affecting the
time required to observe relevant variation in allele frequencies. Nevertheless, these
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